US20060117407A1 - Method of producing transgenic maize using direct transformation of commercially important genotypes - Google Patents

Method of producing transgenic maize using direct transformation of commercially important genotypes Download PDF

Info

Publication number
US20060117407A1
US20060117407A1 US11/071,896 US7189605A US2006117407A1 US 20060117407 A1 US20060117407 A1 US 20060117407A1 US 7189605 A US7189605 A US 7189605A US 2006117407 A1 US2006117407 A1 US 2006117407A1
Authority
US
United States
Prior art keywords
dna sequence
plant
transgenic
endotoxin
zea mays
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/071,896
Inventor
Michael Koziel
Nalini Desai
Kelly Lewis
Vance Kramer
Gregory Warren
Steve Evola
Lyle Crossland
Martha Wright
Ellis Merlin
Karen Launis
Steven Rothstein
Cindy Boyce
John Dawson
Erik Dunder
Gary Pace
Jan Suttie
Nadine Carozzi
Annick De Framond
James Linder
Robert Miller
Bruce Skillings
Alan Mousel
Albert Hornbrook
Christopher Clucas
Moez Meghji
Andreas Tanner
Francis Cassagne
Gilles Pollini
Terry Colbert
Francis Cammack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27533276&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20060117407(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/951,715 external-priority patent/US5625136A/en
Application filed by Individual filed Critical Individual
Priority to US11/071,896 priority Critical patent/US20060117407A1/en
Publication of US20060117407A1 publication Critical patent/US20060117407A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C07K14/325—Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8286—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
    • Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants

Definitions

  • the present invention relates to the transformation of maize genotypes by microprojectile bombardment.
  • A188 genotype known as A188, or derivatives of A188. This is because these lines are easily established in vitro as an embryogenic line that forms Type II, or friable, embryogenic callus and suspension cultures. Such Type II cultures have been exclusively preferred as a recipient of introduced genes. in transformation methods.
  • A188 is an inferior inbred for the development of commercially important hybrids. (Hodges et al., Biotechnology, 4:219, 1986).
  • Working with such “model” maize lines as A188 is disadvantageous in that extensive breeding is usually required in order to develop maize lines with a desirable genetic composition. What is needed is a method that can be used with commercially valuable maize lines without the need for reliance on such “model” systems based on Type II or suspension cultures.
  • Microprojectile bombardment has been advanced as an effective transformation technique for cells, including cells of plants.
  • Sanford et al. Particulate Science and Technology, 5: 27-37 (1987) it was reported that microprojectile bombardment was effective to deliver nucleic acid into the cytoplasm of plant cells of Allium cepa (onion).
  • Christou et al. Plant Physioloqy 87: 671-674 (1988) reported the stable transformation of soybean callus with a kanamycin resistance gene via microprojectile bombardment.
  • Christou et al. reported penetration at approximately 0.1 to 5% of cells.
  • Chri.stou further reported observable levels of NPTII enzyme activity and resistance in the transformed calli of up to 400 mg/L of kanamycin.
  • FIG. 1 shows the plasmid map of the vector pCIB3064 containing the 35S/bar chimeric gene.
  • FIG. 2 shows the plasmid map of the vector pCIB3089 containing the 35S/B-Peru chimeric gene.
  • FIG. 3 shows the plasmid map of the vector pCIB4421 containing the PEP Carboxylase promoter fused to the synthetic BT coding sequence.
  • FIG. 4 shows the plasmid map of the vector pCIB4430 containing the pollen-specific promoter fused to the synthetic BT coding sequence.
  • FIG. 5 shows the plasmid map of the vector pCIB4431 containing the pollen-specifc promoter fused to the synthetic BT coding sequence and the PEP Carboxylase promoter fused to the synthetic BT coding sequence.
  • FIG. 6 shows the plasmid map of the vector pCIB4433 containing the pith-preferred promoter fused to the synthetic BT coding sequence and the 35S/bar chimeric gene.
  • FIG. 7 shows the plasmid map of the vector pCIB4436 containing the 35S/C1 chimeric gene.
  • the present invention is drawn to the stable transformation of maize with nucleic acid sequences of interest, the regeneration of fertile transgenic maize plants and their subsequent use for the creation of commercially valuable lines and hybrids created with those lines.
  • immature zygotic embryos are subjected to high velocity microprojectile bombardment as a means of gene delivery within about 14 days after excision from the plant. After initiation of embryogenic callus and selection for transformed cells, stably transformed plants may be regenerated which express the foreign genes of interest.
  • callus derived from immature zygotic embryos having the Type I character may also be employed as a recipient for gene delivery.
  • the method is applicable to any genotype of maize, especially commercially important ones. In this manner, the method produces transformed maize lines of commercial importance and their hybrid combinations.
  • a method for the transformation of any maize line and the regeneration of transgenic maize plants involves the delivery of nucleic acids, or particularly, genes of interest, directly to immature zygotic embryos.
  • said nucleic acids or genes of interest may be delivered to serially-propagated Type I embryogenic callus obtained from immature zygotic embryos.
  • Stably transformed cells are obtained and are regenerated into whole, fertile plants that express-the foreign gene(s).
  • the fertile transformed plants are capable of producing transformed progeny that express the foreign gene(s).
  • the method provides for the direct transformation of commercially important maize genotypes, for obtaining transformed inbreds and for their hybrid combinations.
  • Somatic embryogenesis is a process by which fully or partially-formed embryos arise from somatic tissue. This- is in contrast to zygotic embryogenesis whereby embryos form from gametic tissue. Somatic embryogenesis may -be induced from several viable tissues of maize, including leaf bases (Conger et al., Pl. Cell Rep. 6:345, 1987), tassel primordia (Rhodes et al., Pl. Sci. 46:225, 1986) and immature embryos (Green et al., Crop Science 15:417, 1975). In the present invention, immature embryos are the preferred source of embryogenic callus.
  • Immature zygotic embryos of maize can be obtained by pollinating an ear with viable pollen then removing the ear from the plant at some later time.
  • immature embryos for use as sources of embryogenic callus are in the size range of about 0.5 mm to about 3.0 mm, more particularly about 1.0 to about 2.5, especially preferred from 1.5 to 2.0.
  • the immature embryos may, for example, be removed from the ear individually by dissection or in bulk by “creaming” the kernels.
  • Isolated immature embryos are placed with the zygotic embryo axis side in contact with an appropriate nutrient medium (Green et al., supra, 1975). Embryogenic callus is typically observed on the immature embryo within about 14 days of placement on the medium.
  • initiation step This initial period is called the “initiation” step.
  • the embryogenic callus is generally transferred to a different medium for establishment and maintenance of serially-propagatable embryogenic callus (called the “maintenance” medium), although the same medium as that for “initiation” may also be used. Incubation of cultures typically takes place at 25 C. in the dark or under low light. Embryogenic callus can be obtained in this way from a wide variety of maize genotypes.
  • Type I embryogenic callus has been defined as “translucent, convoluted and compact callus” (Tomes et al., Theor. Appl. Genet. 70:505-509, 1985) or as “compact, morphologically complex” (Armstrong et al., Planta, 164:207-214 (1985)).
  • Type II embryogenic callus has been defined as “friable and fast growing [callus] with well defined somatic embryos with suspensor-like structures” (Tomes et al;, supra, 1985) or as “friable, embryogenic” (Armstrong et al., supra, 1985).
  • embryogenic callus may be obtained from the immature zygotic embryos, or other viable tissue such as tassel primordia, leaf bases or meristems which may also be used as a source of embryogenic callus.
  • the isolated immature maize embryos must be cultured on an appropriate medium.
  • Many types of medium have been shown to be useful for the establishment of embryogenic callus from a variety of genotypes, including-some commercially important ones (Hodges et al., Bio/Technology 4:219, 1986; Duncan et al., Planta 165:322, 1985).
  • a preferred medium must be found experimentally for each genotype.
  • basal media, sucrose concentrations, and growth regulator types and concentrations are combined in a factorial arrangement. Immature embryos from each genotype to be tested are placed onto medium representing each factorial combination.
  • Initiation frequencies are scored for each medium and the ones producing the highest scores are used in a second round of experimentation.
  • the selected media combinations are further optimized for the individual genotypes by fine-tuning the growth-regulator type and concentration, and sucrose concentration.
  • Table I below indicates the preferred medium for the initiation of embryogenic callus for several of the genotypes disclosed in this invention.
  • the basal media formulas used for the initiation of embryogenic callus of the genotypes in Table I may be found in the following. citations and is herein incorporated by reference: “D”, (Duncan et al., Planta 165:322, 1985); “KM”, (Kao et al., Planta 126:105, 1975); “LM”, (Litvay et al., Plant Cell Reports 4:325, 1985); “MS”, (Murashige et al, Physiologia Plantarum 15:473, 1962).
  • the basal medium “JMS” is the medium known as “SH” (Schenk et al., Can. J. Bot. 50:199, 1972) modified by replacing the inorganic nitrogen compounds with those found in “MS” (Murashige et al., supra, 1962)
  • Genotype Maintenance Medium LH51 MS basal medium, G10 amendments, 3% sucrose, 0.25 mg/L 2,4-D CG00716 N6 basal medium, 25 mM proline, 100 mg casein hydrolysate, 2% sucrose, 1.5 mg/L 2,4-D CG00526 D basal medium, G8 amendments, 2% sucrose, 0.5 mg/L 2,4-D LH82 LM basal medium, G6 amendments, 3% sucrose, 3 mg/L chloramben CG00689 MS basal medium, G10 amendments, 2% sucrose, 1.5 mg/L 2,4-D CGNC4206 D basal medium, G8 amendments, 2% sucrose, 1.2 2,4-D (H99xFR16)xPa91 D basal medium, G4 amendments
  • nucleic acid sequences or genes of interest are delivered to the immature embryos within the “initiation” step of the development of an embryogenic callus, i.e., within about 14 days of the placement of the immature embryos on a nutrient medium capable of supporting the intiation and development of embryogenic callus.
  • the embryogenic callus is transferred to a “maintenance” medium for subculture in either the presence or absence of a selection agent.
  • Type I callus developed using the methods above may also be used as a recipient of the nucleic acid sequences or genes of interest. In this instance, after delivery of the nucleic acid of interest, the Type I embryogenic callus is normally transferred to fresh “maintenance” medium, with or without a selection agent.
  • microprojectile bombardment devices There are available many types of microprojectile bombardment devices, all working on essentially the same principle of accelerating micrometer size particles sufficient to cause penetration into the target tissues and cells. Since it is known that bombardment devices based on gunpowder do not work for the present invention, the preferred devices are those that use some form of gas expansion for the accelerating force for the microprojectiles such as air, carbon dioxide, nitrogen, water vapor or helium. The most preferred device for use in the claimed method is one based on compressed helium such as the DuPont PDS-1000/He.
  • the callus For the bombardment of Type I embryogenic callus, the callus must be subdivided into smaller pieces. This can be achieved by chopping, maceration, dissection or other mechanical means. It is also possible to subdivide the callus through enzymatic means. Enzymes that digest the cell wall or cell-wall components may be used to reduce the integrity of the callus mass. Such enzymes include cellulases, macerases, pectinases, hemi-cellulases and others well known in the art. After the callus is subdivided, it is rinsed several times with liquid culture medium.
  • either the immature embryos or Type I embryogenic callus may optionally be pre-treated with an osmotically-active agent to plasmolyze the cells for a period from about 1 to about 24 hours, preferably from about 1 to about 12 hours, most preferably from about 1 to about 6 hours.
  • the recipient material is treated with a concentration of sucrose that produces an osmotic pressure in the medium that is greater than that in the recipient material.
  • the concentration of sucrose may range from about 2 to about 18%, preferably from about 6 to about 12%.
  • osmotically-active agents may be used in concentrations sufficient to cause the plasmolysis of the cells of the recipient material, such as sorbitol, glucose, mannitol and various molecular weight ranges of polyethylene glycol.
  • the recipient material is kept in the presence of the osmotically-active agent after gene delivery for a period of about 1 to about 24 hours, preferably from about 3 to about 18 hours, most preferably from about 10 to about 18 hours.
  • the set-up and use of the microprojectile bombardment device, as well as the targeting of the recipient material, is described below. Other arrangements are also possible.
  • the DNA is prepared for microprojectile bombardment by chemical precipitation in the presence of micrometer size gold, essentially according to the published procedure of DuPont.
  • micrometer size gold essentially according to the published procedure of DuPont.
  • other dense particles of micrometer size may be used, such as tungsten or platinum.
  • the particles themselves are first prepared by suspending them in water and sonicating. The sonicated particles are then pelleted by centrifugation and resuspended in an aqueous solution of 50% glycerol. Particles prepared in this way are then aliquoted into individual tubes containing approximately 3 mg of gold particles per tube in a volume of 50 ul.
  • DNA is added to each tube in varying amounts, depending upon the number of plasmids to be used, their sizes and the final concentration of DNA desired.
  • 2 ug of pCIB3089, 2 ug pCIB4436, 3 ug pCIB4433 and 4 ug pCIB4430 are added to each tube of aliquoted gold particles.
  • about 50 ul of 2.5 M CaCl2 and about 20 ul of 1M spermidine are added, in that order, to each tube while vortexing for about 3 minutes.
  • the DNA/gold complex is then gently centrifuged.
  • a burst of helium is released by rupture of a plastic disk which is available in different pressure grades.
  • a plastic disk which is available in different pressure grades.
  • single disks, or combinations of disks can be obtained which rupture at 200, 450, 650, 900, 1100 1350, 1550, 1800, 2000 and 2200 pounds per square inch of helium.
  • This burst of gas propels the macrocarrier sheet, which is stopped by a stainless steel screen.
  • the screen may be of different mesh sizes, such as 10 ⁇ 10, 16 ⁇ 16, 24 ⁇ 24, etc.
  • Other settings are the macrocarrier flight distances, gap distance, and particle flight distance. These settings are described in detail in the manufacturer's user's manual.
  • a gap distance of about 5.5 mm, a macrocarrier flight distance of about 10 mm and a particle flight distance of about 6 to 9 cm is-used.
  • a screen or baffle may be inserted within the particle flight distance between the stopping screen and the target plate. Such a screen or baffle disturbs the shock wave from the expanding gas thereby reducing damage to the target.
  • stainless steel screens with an opening of about 100 um is used. Other opening sizes and material composition may be used.
  • the immature embryos or Type I embryogenic callus may be arranged on the target plate in different patterns.
  • optimized patterns were developed for immature embryos.
  • the immature embryos are arranged in a circular pattern, the circle being about 2 cm in diameter.
  • the immature embryos are placed on the periphery of the circle.
  • Approximately 36 immature embryos are placed onto each target plate.
  • the target plate may be angled relative to the microcarrier launch assembly. This ensures maximum saturation of the basipetal portion of the immature embryo by the particle spread. It is the basipetal portion of the immature embryo that gives rise to the embryogenic response.
  • the callus is placed on the periphery of a circle about 1 cm diameter on a nutrient medium.
  • the mechanical settings of the bombardment device may be placed at positions similar or identical to the settings recited above for the bombardment of immature embryos.
  • target pattern and gun settings are interrelated.
  • the use. of other mechanical settings on the microprojectile bombardment device can produce other optimal arrangements of the recipient tissue on the target plate.
  • Other combinations of mechanical settings and target patterns are within the scope of the invention.
  • the recombinant DNA molecules of the invention also can include a marker gene to facilitate selection in recombinant plant cells.
  • markers include resistance to a biocide such as an antibiotic, e.g. kanamycin, hygromycin, chloramphenicol, paramomycin, methotrexate and bleomycin, or a herbicide such as imidazolones, sulfonylureas, glyphosate, phosphinothricin (PPT), glufosinate, or bialaphos. Marker genes are well known in the art.
  • the selection agent phosphinothricin is used in conjunction with the selectable marker gene known as bar, which encodes for the enzyme phosphinothricin acetyltransferase.
  • the bar gene may be operably linked to a constitutive promoter such as the CaMV 35S promoter; the CaMV 19S promoter; A. tumefaciens promoters such as octopine synthase promoters, mannopine synthase promoters, nopaline synthase promoters, or other opine synthase promoters; ubiquitin promoters, actin promoters, histone promoters and tubulin promoters. Other promoters may also be used.
  • the bar coding sequence is operably linked to the CaMV 35S promoter.
  • Selection of transformed cells in vitro is accomplished by including the selection agent of interest in the medium used to induce and support the establishment of embryogenic callus. Only cells in which the selectable marker is integrated into the chromosome and is expressed, i.e., are transformed, will survive the selection agent. Over time, the cells will grow into an embryogenic callus in the presence of the selection agent eventually reaching a mass sufficient for regeneration of whole, fertile plants. Typically, such embryogenic callus can be maintained for long periods of.time in the presence of selection agent and still retain its ability to produce whole, fertile plants.
  • the minimum time required to obtain an embryogenic callus of sufficient mass under selection pressure can range from about 2 weeks to about 24 weeks, more preferably about 4 weeks to about 20 weeks, most preferably about 8 weeks to about 12 weeks.
  • Transformed cells may also be selected in vitro through visual means.
  • a scorable marker is generally used.
  • scorable markers would be the regulatory or structural genes controlling anthocyanin biosynthesis, GUS (beta-glucuronidase), luciferase, opine synthetases, thaumatin, beta-galactosidase, unique synthetic epitopes designed for easy detection by ELISA, phycobiliproteins and various fluorigenic substances.
  • GUS beta-glucuronidase
  • luciferase luciferase
  • opine synthetases thaumatin
  • beta-galactosidase unique synthetic epitopes designed for easy detection by ELISA, phycobiliproteins and various fluorigenic substances.
  • C1 and B-Peru coding sequences for the anthocyanin regulatory genes known in the art as C1 and B-Peru (Goff et al., EMBO Journal, 9: 2517
  • Fertile transformed plants may be regenerated from isolated transformed embryogenic callus by several means.
  • the transformed embryogenic callus is transferred to a nutrient medium devoid of an auxin-type phytohormone, or is passaged through a series of nutrient media with diminishing concentrations of phytohormone.
  • Other phytohormones may be used during the regeneration step, such as cytokinins (both natural and synthetic) and gibbetellins.
  • inhibitors of phytohormone action may also be used, such as silver nitrate, ancymidol or TIBA.
  • Other amendments to the nutrient medium for regeneration such as activated charcoal and various gelling agents are also known in the art.
  • embryogenic callus was removed from maintenance medium containing PPT after 12 weeks and placed on regeneration medium containing MS basal medium, 3% sucrose, 0.25 mg/L 2,4-D and 5 mg/L benzyladenine. After 2 weeks the embryogenic callus began to regenerate and was transferred to MS basal medium with 3% sucrose. Plantlets are obtained during incubation under light. Such plants may be transferred to a greenhouse environment after sufficient root mass has developed.
  • transformed embryogenic callus is transferred from maintenance medium containing phosphinothricin to regeneration medium consisting of MS medium, 3%. sucrose and also containing phosphinothricin. Regeneration under such selective conditions also produces plantlets during incubation under light, which again may be transferred to a greenhouse environment after sufficient root mass has developed.
  • any gene of interest can be used in the methods of the invention.
  • a maize plant can be engineered to express disease and insect resistance genes, genes conferring nutritional value, genes to confer male and/or female sterility, antifungal, antibacterial or antiviral- genes, and the like.
  • the method can be used to transfer any nucleic acid to control gene expression.
  • the DNA to be transferred could encode antisense RNA.
  • the present invention also encompasses the production by the disclosed method of transformed maize plants and progeny containing a gene or genes which encode for and express insecticidal proteins.
  • genes may be derived from the genus Bacillus , for example Bacillus thuringiensis .
  • a complete description of the creation of said gene or genes may be found in U.S. Ser. No. 951,715 which is herein incorporated by reference. A summary of that disclosure- is given below.
  • a nucleic acid sequence of interest in the present invention includes one which encodes the production of an insecticidal toxin, preferably a polypeptide sharing substantially the. amino acid sequence of an insecticidal crystal protein toxin normally produced by Bacillus thuringiensis (BT).
  • the synthetic gene may encode a truncated or full-length insecticidal protein (IP)
  • IP insecticidal protein
  • synthetic nucleic sequences which encode a polypeptide effective against insects of the order Lepidoptera and Coleoptera
  • synthetic nucleic acid sequences which encode a polypeptide having an amino acid sequence essentially the same as one of the crystal protein toxins of Bacillus thuringiensis variety kurstaki, HD-1.
  • the present invention provides the use of synthetic nucleic acid sequences to yield high level expression of active insecticidal proteins in maize plants.
  • the synthetic,nucleic acid sequences of the present invention have been modified to resemble a maize gene in terms of codon usage and G+C content. As a result of these modifications, the synthetic nucleic acid sequences of the present invention do not contain the potential processing sites which are present in the native gene.
  • the resulting synthetic nucleic acid sequences (synthetic BT IP coding sequences) and plant transformation vectors containing this synthetic nucleic acid sequence (synthetic BT IP genes) result in surprisingly increased expression of the synthetic BT IP gene, compared to the native BT IP gene, in terms of insecticidal protein production in plants, particularly maize.
  • the high level of expression results in maize cells and plants that exhibit resistance to lepidopteran insects, preferably European Corn Borer and Diatrea saccharalis , the Sugarcane Borer.
  • This sequence was subsequently modified to eliminate unwanted restriction endonuclease sites, and to create desired restriction endonuclease sites.
  • These modifications were designed to facilitate cloning of the gene without appreciably altering the codon usage or the maize optimized sequence.
  • PCR polymerase chain reaction
  • the protein produced by the synthetic nucleic acid sequence of interest is effective against insects of the order Lepidoptera or Coleoptera .
  • the polypeptide encoded by the synthetic nucleic acid sequence of interest consists essentially of the full-length or a truncated amino acid sequence of an insecticidal protein normally produced by Bacillus thuringiensis var. kurstaki HD-1.
  • the synthetic DNA sequence encodes a polypeptide consisting essentially of a truncated amino acid sequence of the BT CryIA(b) protein.
  • the present invention also encompasses the use of maize optimized coding sequences encoding other polypeptides, including those of other Bacillus thuringiensis insecticidal polypeptides or insecticidal proteins from other sources.
  • cryIB genes from Bacillus thuringiensis can be maize optimized, and then stably introduced into maize plants.
  • nucleic acid sequences of interest which encode insecticidal proteins may be either in the native or synthetic forms, optimized for expression in maize, and derived from any species of the genus Bacillus.
  • insecticidal proteins produced by the nucleic acid sequences of interest in the present invention are expressed in a maize plant in an amount sufficient to control insect pests, i.e. insect controlling amounts. It is recognized that the amount of expression of insecticidal protein in a plant necessary to control insects may vary depending upon species of plant, type of insect, environmental factors and the like. Generally, the insect population will be kept below the economic threshold which varies from plant to plant. For example, to control European corn borer in maize, the economic threshold is 0.5 eggmass/plant which translates to about 10 larvae/plant.
  • the coding sequence of the nucleic acids of interest is a synthetic maize-optimized gene under the control of regulatory elements such as promoters which direct expression of the coding sequence.
  • regulatory elements such as promoters which direct expression of the coding sequence.
  • Such regulatory elements include monocot or maize and other monocot functional promoters to provide expression of the gene in various parts of the maize plant.
  • the regulatory element may be constitutive. That is, it may promote continuous and stable expression of the gene.
  • promoters include but are not limited to the CaMV 35S promoter; the CaMV 19S promoter; A. tumefaciens promoters such as octopine synthase promoters, mannopine synthase promoters, nopaline synthase promoters, or other opine synthase promoters; ubiquitin promoters, actin promoters, histone promoters and tubulin promoters.
  • the regulatory element may also be a tissue-preferential or tissue-specific promoter.
  • tissue-preferred promoter is used to indicate that a given regulatory DNA sequence will promote a higher level of transcription of an associated structural gene or DNA coding sequence, or of expression of the product of the associated gene as indicated by any conventional RNA or protein assay, or that a given DNA sequence will demonstrate some differential effect; i.e., that the transcription of the associated DNA sequences or the expression of a gene product is greater in some tissue than in all other tissues of the plant.
  • the tissue-preferential promoter may direct higher expression of the synthetic gene in leaves, stems, roots and/or pollen than in seed.
  • tissue-specific promoter is used to indicate that a given regulatory DNA sequence will promote transcription of an associated coding DNA sequence essentially entirely in one or more tissues of a plant, or in one type of tissue, e.g. green tissue, while essentially no transcription of that associated coding DNA sequence will occur in all other tissues or types of tissues of the plant.
  • Numerous promoters whose expression are known to vary in a tissue specific manner are known in the art.
  • One such example is the maize phosphoenol pyruvate carboxylase (PEPC), which is green tissue-specific. See, for example, Hudspeth, R.L. and Grula, J. W., Plant Molecular Biology 12:579-589, 1989.
  • Other green tissue-specific promoters include chlorophyll a/b binding protein promoters and RubisCO small subunit promoters.
  • the regulatory element may also be inducible, such as by heat stress, water stress, insect feeding or chemical induction, or may be developmentally regulated.
  • the regulatory element is a pith-preferred promoter isolated from a maize TrpA gene.
  • TrpA maize tryptophan synthase-alpha subunit gene
  • Each subunit can operate separately, but they function more efficiently together.
  • the nucleic acids of interest in the present invention also include purified pollen-specific promoters obtainable from a plant calcium-dependent phosphate kinase (CDPK) gene. That is, in its native state, the promoter is operably linked to a plant CDPK gene. In a preferred embodiment, the promoter is isolated from a maize CDPK gene.
  • CDPK calcium-dependent phosphate kinase
  • polyze CDPK a plant calcium-dependent phosphate kinase
  • the regulatory element is a root-preferential promoter.
  • a root-preferential promoter was isolated from a gene whose cDNA was found by differential screening of a CDNA library from maize. A CDNA clone so obtained was used to isolate a homologous genomic clone from maize. The protein encoded by the isolated clone was identified as a metallothionein-like protein.
  • Maize is easily hybridized because of the physical distance between the tassel (male part) and the ear (female part).
  • the method of hybridization first involves the development of inbred lines.
  • Inbred lines are maize plants that are essentially the same genetically from generation to generation. Inbreds are produced by taking the pollen from one maize plant and transferring the pollen to the silk of a receptive maize ear of that same plant. Selections for uniformity and agronomic performance are made and the process is repeated until the.seeds from the ears of the plants produce genetically the same plants and. the line is pure.
  • a hybrid maize plant is produced by crossing one elite inbred maize plant with one or more other, genetically different and diverse, inbred maize plant.
  • the crossing consists of taking the pollen from one inbred elite maize plant and transferring the pollen to the silk of a receptive ear of the other elite inbred maize plant.
  • the seed from crossing of two inbreds is a first generation hybrid and is called a F1.
  • the F1 of commercially valuable inbreds have better yields, standability, and improvement in other important characteristics than either of the parents. This phenomenon is called hybrid vigor.
  • inbred lines of maize are directly transformed through the disclosed methods of delivering nucleic acid sequences of interest to either immature zygotic embryos obtained from such lines or Type I embryogenic callus derived from immature zygotic embryos of such lines.
  • the ability to directly transform maize lines of commercial value is a distinct advantage of the claimed invention in that the generations of backcrossing required when the starting material is not commercially valuable can be avoided, thereby reducing the time and cost of commercialization.
  • the present invention also discloses the direct transformation of hybrids of inbred lines using the claimed methods.
  • any hybrid expressing a gene of interest can be created by transforming an inbred line with the gene of interest and using such transformed line to create the hybrid.
  • a transformed hybrid may also be obtained according to the present invention by directly transforming either immature zygotic embryos obtained from said hybrid plant or by transforming Type I embryogenic callus derived from immature zygotic embryos obtained from said hybrid plant.
  • anthocyanin pigmentation it is also possible to produce maize plants that have an altered phenotype of anthocyanin pigmentation.
  • This can be accomplished through the use of the disclosed chimeric genes for the constitutive promotion of the genes known as C1 and B-Peru. That activation of the biosynthetic pathway for anthocyanin can be achieved in this way in embryogenic callus was reported by Goff et al., EMBO Journal, 9: 2517-2522, 1990.
  • the above said genes were used to produce plants and progeny according to the claimed method whose color phenotype was altered.
  • ig Monoploid inducing gene known as ig (Kermicle, Science 166:1422-1424, 1969) can be used to create a haploid having a paternal nuclear constitution.
  • Monoploid inducers creating a haploid having a maternal nuclear constitution ate also known (for example, Coe, The American Naturalist , XCIII: 381-382, 1959). Because of the low frequency of such an event, it would be advantageous to have an easily screened color phenotype which would allow the identification of the haploids.
  • Transformed plants were assayed for insecticidal activity and the presence of a BT protein resulting from the expression of the maize-optimized coding sequence of a synthetic BT gene.
  • the procedure is similar for any maize plant transformed with a BT gene but is described here using as an example a cryIA(b) gene, its expressed product, and resistance to European corn borer.
  • Insecticidal activity was determined by insect bioassay.
  • One to four 4 cm sections are cut from an extended leaf of a transformed maize plant. Each leaf piece is placed on a moistened filter disc in a 50 ⁇ 9 mm petri dish. Five neonate European corn borer larvae are placed on each leaf piece. Since each plant is sampled multiple times this makes a total of 5-20 larvae per plant.
  • the petri dishes are incubated at 29.5° C. and leaf feeding damage and mortality data are scored at 24, 48, and 72 hours.
  • Immunoaffinity purified polyclonal rabbit and goat antibodies specific for the B. thuringiensis subsp. kurstaki IP were used to determine ng IP per mg soluble protein from crude extracts of leaf samples.
  • the sensitivity of the double sandwich ELISA is 1-5 ng IP per mg soluble protein using 50 ug of total protein per ELISA microtiter dish well.
  • Corn extracts were made by grinding leaf tissue in gauze lined plastic bags using a hand held ball-bearing homogenizer (AGDIA, Elkart IN.) in the presence of extraction buffer (50 mM Na2CO3 pH 9.5, 100 mM NaCl, 0.05% Triton, 0.05% Tween, 1 mM PMSF and 1 pM leupeptin). Protein determination was performed using the Bio-Rad (Richmond, CA) protein assay.
  • Immature embryos for experiment KC-65 were obtained approximately 14 days after self-pollination.
  • the immature zygotic embryos were divided among different target plates containing medium capable of inducing and supporting embryogenic callus formation at 36 immature embryos per plate.
  • the immature zygotic embryos were bombarded with a mixture of the plasmids pCIB3064 and pCIB4431 using the PDS-1000/He device from DuPont.
  • the plasmids were precipitated onto 1 um gold particles essentially according to the published procedure from DuPont, as described.above. Each target plate was shot one-time with the plasmid and gold preparation.
  • the plasmid pCIB3064 contained a chimeric gene coding for resistance to phosphinothricin this substance was used to select transformed cells in vitro. This selection was applied at 3 mg/L one day after bombardment and maintained for a total of 12 weeks. The embryogenic callus so obtained was regenerated in the absence of the selection agent phosphinothricin. Plants were obtained from one isolated line of embryogenic callus and given the Event Number 176. All plants were tested by the chlorophenol red (CR) test for resistance to PPT as described in U.S.
  • This assay utilizes a pH sensitive indicator dye to show which cells are growing in the presence of PPT. Cells which grow produce a pH change in the media and turn the indicator yellow (from red). Plants expressing the resistance gene to PPT are easily seen in this test. Of the 38 plants regenerated for Event Number 176, eight were positive in this test and 30 were negative. Plants positive by the CR test were assayed by PCR for the presence of the synthetic BT gene. Of the eight positive plants from the CR test, 5 were positive for the presence of the synthetic BT gene, 2 were negative and 1 died during propagation. These five remaining plants were bioassayed and found to be resistant to European Corn Borer. DNA was isolated from plant #11 using standard techniques and analysed by Southern blot analysis.
  • Plant 11 was shown by ELISA to contain 2,195 ng BT protein per mg soluble protein in the leaf tissue, consistent with the use of the leaf-specific promoter from PEPC operably linked to a synthetic BT gene. Plants resistant to European Corn Borer and expressing the introduced BT gene are transformed.
  • Ear number ED42 was self-pollinated and immature zygotic embryos were obtained approximately 10 days later. Two hundred and eighty eight immature zygotic embryos were divided among 7 different target plates containing a medium capable of inducing and supporting the formation of embryogenic callus. After two days, the immature zygotic embryos were transferred to the same medium but containing 12% sucrose. After 5 hours, the immature zygotic embryos were bombarded with a mixture of the plasmids pCIB3089, pCIB4430, pCIB4433, pCIB4436 using the PDS-1000/He device from DuPont.
  • the plasmids were precipitated onto 1 um gold particles essentially according to the published procedure from DuPont, as described above. The particles were delivered using burst pressures of 450, 650 and 900 psi of helium. Each target plate was shot twice with the plasmid and gold particle preparation. After overnight incubation, the immature embryos were transferred to fresh maintenance medium containing 2% sucrose. Since the plasmids pCIB3089 and pCIB4436 contain the C1 and B-Peru genes which regulate anthocyanin production, the appearance of red, multicellular sectors on the developing embryogenic callus was used to select and isolate transformed cells, eventually obtaining a homogeneous callus line.
  • Embryogenic callus was regenerated in both the absence and presence of the selection agent phosphinothricin, resistance to which was conferred by a chimeric gene present in plasmid pCIB4433.
  • Plants were obtained from a total of nine isolated embryogenic callus lines and were given the Event Numbers 197, 198, 208, 211, 219, 255, 261, 281 and 284.
  • Leaf tissue from plants from each event were assayed for resistance to European Corn Borer. Plants from Event Numbers 208 and 211 were susceptible to European Corn Borer whereas plants from Event Numbers 197, 198, 219, 255, and 261 were resistant. All the plants that were resistant to European Corn Borer also expressed the introduced, leaf-specific PEPC-promoted synthetic BT gene as evidenced by thd detection of BT protein using an ELISA assay.
  • Plants resistant to European Corn Borer and expressing the introduced BT gene are transformed.
  • Ear number ED47 was self-pollinated and immature zygotic embryos were obtained approximately 10 days later. Approximately two hundred and sixty immature zygotic embryos were divided among 8 different target plates containing a medium capable of inducing and supporting the formation of embryogenic callus. After two days, the immature zygotic embryos were transferred to the same medium but containing 12% sucrose. After 5 hours, the immature zygotic embryos were bombarded with a mixture of the plasmids pCIB3089, pCIB4430, pCIB4433, pCIB4436 using the PDS-1000/He device from DuPont.
  • the plasmids were precipitated onto 1 um gold particles essentially according to the published procedure from DuPont, as described above. The particles were delivered using a burst pressure of 900 psi of helium. Each target plate was shot twice with the plasmid and gold particle preparation. After overnight incubation, -the immature embryos were transferred to fresh maintenance medium containing 2% sucrose. Since the plasmid pCIB4433 contained a chimeric gene coding for resistance to phosphinothricin this substance was used to select transformed cells in vitro. The selection agent was applied at 10 mg/L 14 days after gene delivery and increased to 20-40 mg/L after approximately one month.
  • the embryogenic callus so obtained was regenerated in the presence of the selection agent phosphinothricin.
  • Plants were obtained from a total of eleven isolated embryogenic callus lines and were given the Event Numbers 220, 221, 222, 223, 225, 230, 231, 232, 233, 269, 274. Plants from each event were assayed for resistance to European Corn Borer. Leaf tissue of plants from Event Numbers 220, 221, 222, 223, 225, 231 and 233 were resistant. All the plants that were resistant to European Corn Borer also expressed the introduced, leaf-specific PEPC-promoted synthetic BT gene as evidenced by the detection of BT protein using an ELISA assay. Plants resistant to European Corn Borer and expressing the introduced BT gene are transformed. Plants from Event Numbers 230, 232, 269 and 274 were not completely tested.
  • Type I callus was obtained from immature zygotic embryos using standard culture techniques. For gene delivery, approximately 300 mg of the Type I callus was prepared by chopping with a scalpel blade, rinsing 3 times with standard culture media containing 18% sucrose and immediately placed onto semi-solid culture medium again containing 18% sucrose. After approximately 4 hours, the tissue was bombarded using the PDS-1000/He Biolistic device from DuPont. The plasmids pCIB4430 and pCIB4433 were precipitated onto 1 um gold particles using the standard protocol from DuPont. Approximately 16 hours after gene delivery the callus was transferred to standard culture medium containing 2% sucrose and 10 mg/L phosphinothricin as Basta. The callus was subcultured on selection for 8 weeks, after which surviving and growing callus was transferred to standard regeneration medium for the production of plants.
  • Type I callus was obtained from immature zygotic embryos using standard culture techniques. For gene delivery, approximately 300 mg of the Type I callus was prepared by chopping with a scalpel blade, rinsing 3 times with standard culture media containing 12% sucrose and immediately placed onto semi-solid culture medium again containing 12% sucrose. After approximately 4 hours, the tissue was bombarded using the PDS-1000/He Biolistic device from DuPont. The plasmids pCIB4430 and pCIB4433 were precipitated onto 1 um gold particles using essentially the standard protocol from DuPont as described above. Approximately 16 hours after gene delivery the callus was transferred to standard culture medium containing 2% sucrose and 1 mg/L phosphinothricin as Basta. The callus was subcultured on selection for 8 weeks, after which surviving and growing callus was transferred to standard regeneration medium for the production of plants.
  • Ear numbers JS21, JS22, JS23, JS24 and JS25 were self-pollinated and immature zygotic embryos were obtained approximately 10 days later. Approximately eight hundred and forty immature zygotic embryos were divided among 14 different target plates containing a medium capable of inducing and supporting the formation of embryogenic callus. The immature zygotic embryos were transferred immediately to the same medium but containing 12% sucrose. After 5 hours, the immature zygotic embryos were bombarded with a mixture of the plasmids pCIB3089, pCIB4433, pCIB4436 using the PDS-1000/He device from DuPont.
  • the plasmids were precipitated onto 1 um gold particles essentially according to the published procedure from DuPont, as described above. The particles were delivered using a burst pressure of 1550 psi of helium. Each target plate was shot twice with the plasmid and gold particle preparation. Since the plasmid pCIB4433 contained a chimeric gene coding for resistance to phosphinothricin this substance was used to select transformed cells in vitro. The selection agent was applied at 10 mg/L on the day of gene delivery and increased to 40 mg/L after approximately one month. The embryogenic callus so obtained was regenerated in the presence of the selection agent phosphinothricin.
  • Plants were obtained from a total of eight isolated embryogenic callus lines and were given the Event Numbers 187, 188, 191, 192, 193, 196, 228 and 229. Plants from each event were assayed for resistance to European Corn Borer. Plants from Event Numbers 191 and 193 exhibited insect resistance in the pith in accordance with the use of the pith-preferred synthetic BT construct. All the plants that were resistant to European Corn Borer also expressed the introduced chimeric BT gene as evidenced by the detection of BT protein in the pith using an ELISA assay. Plants resistant to European Corn Borer and expressing the introduced BT gene are transformed.
  • Ear numbers GP5 and JS26 were self-pollinated and immature zygotic embryos were obtained approximately 10 days later. Approximately three hundred and thirty immature zygotic embryos were divided among 5 different target-plates containing a medium capable of inducing and supporting the formation of embryogenic callus. After two days the immature zygotic embryos were transferred to the same medium but containing 12% sucrose. After approximately 5 hours, the immature zygotic embryos were bombarded with a mixture of the plasmids pCIB3089, pCIB4430, pCIB4433, pCIB4436 using the PDS-1000/He device from DuPont.
  • the plasmids were precipitated onto 1 um gold particles essentially according to the published procedure from DuPont, as described above. The particles were delivered using a burst pressure of 1300 psi of helium. Each target plate was shot twice with the plasmid and gold particle preparation. Since the plasmid pCIB4433 contained a chimeric gene coding for resistance to phosphinothricin this substance was used to select transformed cells in vitro. The selection agent was applied at 10 mg/L 3 weeks after the day of gene delivery. The embryogenic callus so obtained was regenerated. Plants were obtained from three isolated embryogenic callus lines and were given the Event Numbers 242, 247 and 260. Plants from each event were assayed for resistance to European Corn Borer. Plants from Event Numbers 247 and 260 exhibited insect resistance indicating that they were transformed.
  • Immature zygotic embryos for. the experiment KM-124 were obtained approximately 14 days after self-pollination. Approximately one hundred and five immature zygotic embryos were divided among 4 different target plates containing a medium capable of inducing and supporting the formation of embryogenic callus. The immature zygotic embryos were bombarded with a mixture of the plasmids pCIB4421 and pCIB4433 using the PDS-1000/He device from DuPont.
  • the plasmids were-precipitated onto 1 um gold particles essentially according to the published procedure from DuPont, as described above. The particles were delivered using a burst pressure of 1550 psi of helium. Each target plate was shot once with the plasmid and gold particle preparation. Since the plasmid pCIB4433 contained a chimeric gene coding for resistance to phosphinothricin this substance was used, as Basta, to select transformed cells in vitro. The selection agent was applied at 5 mg/L one day after gene delivery and maintained for a total of 12 weeks. The embryogenic callus so obtained was regenerated in the absence of the selection agent phosphinothricin. Plants were obtained from one isolated embryogenic callus line and was given the Event Number 268. Plants were assayed for resistance to European Corn Borer. One of the 5 plants obtained is resistant to European Corn Borer and is transformed.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Pest Control & Pesticides (AREA)
  • Physics & Mathematics (AREA)
  • Insects & Arthropods (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Methods for transformation of maize with nucleic acid sequences of interest are disclosed. The method involves subjecting immature zygotic embryos or Type I callus to high velocity microprojectile bombardment. The method is capable of producing transformed maize lines of commercial importance and their hybrid combinations.

Description

  • This application is a continuation-in-part application of U.S. Ser. No. 951, 715 filed Sep. 25, 1992, which is a continuation-in-part application of U.S. Ser. No. 772, 027 filed Oct. 4, 1991 which disclosures are herein incorporated in their entirety.
  • FIELD OF THE INVENTION
  • The present invention relates to the transformation of maize genotypes by microprojectile bombardment.
  • BACKGROUND OF THE INVENTION
  • The use of genetic engineering to introduce new agronomically important traits into maize such as insect resistance will have many commercial benefits. In order to accomplish this in the most expedient fashion it is necessary to have a method of transformation that can be used with maize genotypes that are commercially valuable.
  • The majority of instances of maize transformation have used a genotype known as A188, or derivatives of A188. This is because these lines are easily established in vitro as an embryogenic line that forms Type II, or friable, embryogenic callus and suspension cultures. Such Type II cultures have been exclusively preferred as a recipient of introduced genes. in transformation methods. Unfortunately, A188 is an inferior inbred for the development of commercially important hybrids. (Hodges et al., Biotechnology, 4:219, 1986). Working with such “model” maize lines as A188 is disadvantageous in that extensive breeding is usually required in order to develop maize lines with a desirable genetic composition. What is needed is a method that can be used with commercially valuable maize lines without the need for reliance on such “model” systems based on Type II or suspension cultures.
  • Microprojectile bombardment has been advanced as an effective transformation technique for cells, including cells of plants. In Sanford et al., Particulate Science and Technology, 5: 27-37 (1987) it was reported that microprojectile bombardment was effective to deliver nucleic acid into the cytoplasm of plant cells of Allium cepa (onion). Christou et al., Plant Physioloqy 87: 671-674 (1988) reported the stable transformation of soybean callus with a kanamycin resistance gene via microprojectile bombardment. Christou et al. reported penetration at approximately 0.1 to 5% of cells. Chri.stou further reported observable levels of NPTII enzyme activity and resistance in the transformed calli of up to 400 mg/L of kanamycin. McCabe et al., Bio/Technology 6: 923-926 (1988) report the stable transformation of Glycine max (soybean) using microprojectile bombardment. McCabe et al. further report the recovery of a transformed R1 plant from an R0 chimeric plant.
  • Transformation of monocots and, in particular, commercially. valuable maize lines, has been problematic. Although there have been several reports of stable plant transformation utilizing the microprojectile bombardment technique, such transformation has not resulted in the production of fertile, regenerated transgenic maize plants of a commercially. valuable genotype—each report used the genotype A188 or its derivatives (Fromm et al, BioTechnology, 8:833, 1990; Walters et al., Pl. Mol. Biol. 18:189, 1.992, Gordon-Kamm et al., Plant Cell, 2:603, 1990). There are two reports of maize transformation using commercially valuable lines but both rely on the availability of Type II, friable embryogenic callus as a recipient for gene delivery (Jayne et al., 1991 Meeting of the International Society for Plant Molecular Biology, Abstract #338; Aves et al., 1992 World Congress on Cell and Tissue Culture, In Vitro 28:124A, Abstract #P-1134).
  • Prior to the present invention, successful direct transformation of commercially valuable maize lines has not been achieved using microprojectile bombardment of immature zygotic embryos or Type I embryogenic callus.
  • BRIEF DESCRIPTION OF THE FIGURES
  • FIG. 1 shows the plasmid map of the vector pCIB3064 containing the 35S/bar chimeric gene.
  • FIG. 2 shows the plasmid map of the vector pCIB3089 containing the 35S/B-Peru chimeric gene.
  • FIG. 3 shows the plasmid map of the vector pCIB4421 containing the PEP Carboxylase promoter fused to the synthetic BT coding sequence.
  • FIG. 4 shows the plasmid map of the vector pCIB4430 containing the pollen-specific promoter fused to the synthetic BT coding sequence.
  • FIG. 5 shows the plasmid map of the vector pCIB4431 containing the pollen-specifc promoter fused to the synthetic BT coding sequence and the PEP Carboxylase promoter fused to the synthetic BT coding sequence.
  • FIG. 6 shows the plasmid map of the vector pCIB4433 containing the pith-preferred promoter fused to the synthetic BT coding sequence and the 35S/bar chimeric gene.
  • FIG. 7 shows the plasmid map of the vector pCIB4436 containing the 35S/C1 chimeric gene.
  • SUMMARY OF THE INVENTION
  • The present invention is drawn to the stable transformation of maize with nucleic acid sequences of interest, the regeneration of fertile transgenic maize plants and their subsequent use for the creation of commercially valuable lines and hybrids created with those lines. In the invention, immature zygotic embryos are subjected to high velocity microprojectile bombardment as a means of gene delivery within about 14 days after excision from the plant. After initiation of embryogenic callus and selection for transformed cells, stably transformed plants may be regenerated which express the foreign genes of interest. Alternatively, callus derived from immature zygotic embryos having the Type I character may also be employed as a recipient for gene delivery. The method is applicable to any genotype of maize, especially commercially important ones. In this manner, the method produces transformed maize lines of commercial importance and their hybrid combinations.
  • DETAILED DESCRIPTION OF THE INVENTION
  • A method for the transformation of any maize line and the regeneration of transgenic maize plants is provided. The method involves the delivery of nucleic acids, or particularly, genes of interest, directly to immature zygotic embryos. Alternatively, said nucleic acids or genes of interest may be delivered to serially-propagated Type I embryogenic callus obtained from immature zygotic embryos. Stably transformed cells are obtained and are regenerated into whole, fertile plants that express-the foreign gene(s). Furthermore, the fertile transformed plants are capable of producing transformed progeny that express the foreign gene(s). The method provides for the direct transformation of commercially important maize genotypes, for obtaining transformed inbreds and for their hybrid combinations.
  • Embryogenic callus of maize is obtained by the process of somatic embryogenesis. Somatic embryogenesis is a process by which fully or partially-formed embryos arise from somatic tissue. This- is in contrast to zygotic embryogenesis whereby embryos form from gametic tissue. Somatic embryogenesis may -be induced from several viable tissues of maize, including leaf bases (Conger et al., Pl. Cell Rep. 6:345, 1987), tassel primordia (Rhodes et al., Pl. Sci. 46:225, 1986) and immature embryos (Green et al., Crop Science 15:417, 1975). In the present invention, immature embryos are the preferred source of embryogenic callus.
  • Immature zygotic embryos of maize can be obtained by pollinating an ear with viable pollen then removing the ear from the plant at some later time. Typically, immature embryos for use as sources of embryogenic callus are in the size range of about 0.5 mm to about 3.0 mm, more particularly about 1.0 to about 2.5, especially preferred from 1.5 to 2.0. The immature embryos may, for example, be removed from the ear individually by dissection or in bulk by “creaming” the kernels. Isolated immature embryos are placed with the zygotic embryo axis side in contact with an appropriate nutrient medium (Green et al., supra, 1975). Embryogenic callus is typically observed on the immature embryo within about 14 days of placement on the medium. This initial period is called the “initiation” step. After the initiation step, the embryogenic callus is generally transferred to a different medium for establishment and maintenance of serially-propagatable embryogenic callus (called the “maintenance” medium), although the same medium as that for “initiation” may also be used. Incubation of cultures typically takes place at 25 C. in the dark or under low light. Embryogenic callus can be obtained in this way from a wide variety of maize genotypes.
  • Two main types of embryogenic callus have been described in the scientific literature. Type I embryogenic callus has been defined as “translucent, convoluted and compact callus” (Tomes et al., Theor. Appl. Genet. 70:505-509, 1985) or as “compact, morphologically complex” (Armstrong et al., Planta, 164:207-214 (1985)). Type II embryogenic callus has been defined as “friable and fast growing [callus] with well defined somatic embryos with suspensor-like structures” (Tomes et al;, supra, 1985) or as “friable, embryogenic” (Armstrong et al., supra, 1985). It is within the scope of this invention that either or both types of embryogenic callus may be obtained from the immature zygotic embryos, or other viable tissue such as tassel primordia, leaf bases or meristems which may also be used as a source of embryogenic callus.
  • In order to obtain embryogenic callus the isolated immature maize embryos must be cultured on an appropriate medium. Many types of medium have been shown to be useful for the establishment of embryogenic callus from a variety of genotypes, including-some commercially important ones (Hodges et al., Bio/Technology 4:219, 1986; Duncan et al., Planta 165:322, 1985). In practice, a preferred medium must be found experimentally for each genotype. Typically in such an experimental procedure a selection of basal media, sucrose concentrations, and growth regulator types and concentrations are combined in a factorial arrangement. Immature embryos from each genotype to be tested are placed onto medium representing each factorial combination. Initiation frequencies are scored for each medium and the ones producing the highest scores are used in a second round of experimentation. In this second round, the selected media combinations are further optimized for the individual genotypes by fine-tuning the growth-regulator type and concentration, and sucrose concentration. For example, Table I below indicates the preferred medium for the initiation of embryogenic callus for several of the genotypes disclosed in this invention.
    TABLE I
    Genotype Initiation Medium
    LH51 MS basal medium, G10 amendments, 6% sucrose,
    5 mg/L dicamba
    CG00716 JMS basal medium, G5 amendments, 9% sucrose,
    5 mg/L dicamba
    CG00526 D basal medium, G8 amendments, 2% sucrose,
    5 mg/L chloramben
    CG00642 JMS basal medium, G5 amendments, 10% sucrose,
    4 mg/L dicamba
    LH82 LM basal medium, G6 amendments, 4% sucrose,
    0.2 mg/L 2,4-D
    CG00689 MS basal medium, G1 amendments, 6% sucrose,
    0.5 mg/L 2,4-D
    CGNC4206 MS basal medium, G1 amendments, 6% sucrose,
    0.5 2,4-D
    CG00629 D basal medium, G8 amendments, 2% sucrose,
    5 mg/L chloramben
    (H99xFR16)xPa91 JMS basal medium, G5 amendments, 2% sucrose,
    1 mg/l dicamba
    Hi II JMS basal medium, G5 amendments, 2% sucrose,
    10 mg/L silver nitrate, 5 mg/L dicamba
  • The basal media formulas used for the initiation of embryogenic callus of the genotypes in Table I may be found in the following. citations and is herein incorporated by reference: “D”, (Duncan et al., Planta 165:322, 1985); “KM”, (Kao et al., Planta 126:105, 1975); “LM”, (Litvay et al., Plant Cell Reports 4:325, 1985); “MS”, (Murashige et al, Physiologia Plantarum 15:473, 1962). The basal medium “JMS” is the medium known as “SH” (Schenk et al., Can. J. Bot. 50:199, 1972) modified by replacing the inorganic nitrogen compounds with those found in “MS” (Murashige et al., supra, 1962)
  • The formulas of the amendments used for the initiation of embryogenic callus of the genotypes in Table II are found in the following table. The amendments used with the “KM” basal medium were as described in Kao et al., supra, 1975).
    TABLE II
    Amendment Formulas, per Liter of Medium
    G1 G5 G6 G8 G10
    Component mg
    Nicotinic Acid 0.5 5.0 0.5 0.2 0.5
    Pyridoxine-HCl 0.5 0.5 0.1 0.2 0.5
    Thiamine-HCl 0.1 5.0 0.1 0.5 0.1
    Glycine 2.0 — — — 2.0
    myo-Inositol 100 100 100 — 100
    Choline HCl — — — 0.1 —
    Riboflavin — — — 0.1 —
    Biotin — — — 0.1 —
    Folic Acid — — — 0.5 -
    CaPantothenate — — — 0.1 —
    Cyanocobalamin — — — 0.014 —
    Casein hydrolysate 100 100 100 — —
    Proline 2800 2800 2800 — —
  • Often, the preferred “maintenance” medium must be determined experimentally, as is done for “initiation”. Table III describes the “maintenance” medium found to be useful for several of the genotypes disclosed in the present invention.
    TABLE III
    Genotype Maintenance Medium
    LH51 MS basal medium, G10 amendments, 3% sucrose,
    0.25 mg/L 2,4-D
    CG00716 N6 basal medium, 25 mM proline, 100 mg casein
    hydrolysate, 2% sucrose, 1.5 mg/L 2,4-D
    CG00526 D basal medium, G8 amendments, 2% sucrose,
    0.5 mg/L 2,4-D
    LH82 LM basal medium, G6 amendments, 3% sucrose,
    3 mg/L chloramben
    CG00689 MS basal medium, G10 amendments, 2% sucrose,
    1.5 mg/L 2,4-D
    CGNC4206 D basal medium, G8 amendments, 2% sucrose,
    1.2 2,4-D
    (H99xFR16)xPa91 D basal medium, G4 amendments, 2% sucrose,
    0.5 mg/l 2,4-D
    Hi II N6 basal medium, G5 amendments, 2% sucrose,
    1 mg/L 2,4-D

    In Table III, “N6” basal medium refers to that described in Chu et al. Scientia Sinica, XVIII: 659, 1975. The formulas for the amendments used in “maintenance” medium may be found in Table II.
  • According to the present invention, nucleic acid sequences or genes of interest are delivered to the immature embryos within the “initiation” step of the development of an embryogenic callus, i.e., within about 14 days of the placement of the immature embryos on a nutrient medium capable of supporting the intiation and development of embryogenic callus. After gene delivery and initiation of embryogenic callus, the embryogenic callus is transferred to a “maintenance” medium for subculture in either the presence or absence of a selection agent. In another embodiment of the invention, Type I callus developed using the methods above may also be used as a recipient of the nucleic acid sequences or genes of interest. In this instance, after delivery of the nucleic acid of interest, the Type I embryogenic callus is normally transferred to fresh “maintenance” medium, with or without a selection agent.
  • There are available many types of microprojectile bombardment devices, all working on essentially the same principle of accelerating micrometer size particles sufficient to cause penetration into the target tissues and cells. Since it is known that bombardment devices based on gunpowder do not work for the present invention, the preferred devices are those that use some form of gas expansion for the accelerating force for the microprojectiles such as air, carbon dioxide, nitrogen, water vapor or helium. The most preferred device for use in the claimed method is one based on compressed helium such as the DuPont PDS-1000/He.
  • For the bombardment of Type I embryogenic callus, the callus must be subdivided into smaller pieces. This can be achieved by chopping, maceration, dissection or other mechanical means. It is also possible to subdivide the callus through enzymatic means. Enzymes that digest the cell wall or cell-wall components may be used to reduce the integrity of the callus mass. Such enzymes include cellulases, macerases, pectinases, hemi-cellulases and others well known in the art. After the callus is subdivided, it is rinsed several times with liquid culture medium.
  • In preparation for gene delivery by microprojectile bombardment, either the immature embryos or Type I embryogenic callus may optionally be pre-treated with an osmotically-active agent to plasmolyze the cells for a period from about 1 to about 24 hours, preferably from about 1 to about 12 hours, most preferably from about 1 to about 6 hours. Typically, the recipient material is treated with a concentration of sucrose that produces an osmotic pressure in the medium that is greater than that in the recipient material. The concentration of sucrose may range from about 2 to about 18%, preferably from about 6 to about 12%. It is also within the scope of this invention that other osmotically-active agents may be used in concentrations sufficient to cause the plasmolysis of the cells of the recipient material, such as sorbitol, glucose, mannitol and various molecular weight ranges of polyethylene glycol. The recipient material is kept in the presence of the osmotically-active agent after gene delivery for a period of about 1 to about 24 hours, preferably from about 3 to about 18 hours, most preferably from about 10 to about 18 hours.
  • In a preferred embodiment of the invention, the set-up and use of the microprojectile bombardment device, as well as the targeting of the recipient material, is described below. Other arrangements are also possible.
  • The DNA is prepared for microprojectile bombardment by chemical precipitation in the presence of micrometer size gold, essentially according to the published procedure of DuPont. In addition to gold, other dense particles of micrometer size may be used, such as tungsten or platinum. In one modification of the DuPont procedure, the particles themselves are first prepared by suspending them in water and sonicating. The sonicated particles are then pelleted by centrifugation and resuspended in an aqueous solution of 50% glycerol. Particles prepared in this way are then aliquoted into individual tubes containing approximately 3 mg of gold particles per tube in a volume of 50 ul. DNA is added to each tube in varying amounts, depending upon the number of plasmids to be used, their sizes and the final concentration of DNA desired. For example, in a typical preparation to include four plasmids for use in the present invention, 2 ug of pCIB3089, 2 ug pCIB4436, 3 ug pCIB4433 and 4 ug pCIB4430 are added to each tube of aliquoted gold particles. Next, about 50 ul of 2.5 M CaCl2 and about 20 ul of 1M spermidine are added, in that order, to each tube while vortexing for about 3 minutes. The DNA/gold complex is then gently centrifuged. The supernatant is removed, the particles are washed once with 250 ul of absolute ethanol, pelleted again and then resuspended in about 75 ul bf fresh absolute ethanol. Each tube prepared in this way is enough of the DNA/gold complex for six “shots” with the PDS-1000/He. Ten ul of the well-suspended DNA/gold complex is pipetted onto the macrocarrier sheet in a vibration-free environment.
  • In the PDS-1000/He device, a burst of helium is released by rupture of a plastic disk which is available in different pressure grades. For example, single disks, or combinations of disks, can be obtained which rupture at 200, 450, 650, 900, 1100 1350, 1550, 1800, 2000 and 2200 pounds per square inch of helium. This burst of gas propels the macrocarrier sheet, which is stopped by a stainless steel screen. The screen may be of different mesh sizes, such as 10×10, 16×16, 24×24, etc. Other settings are the macrocarrier flight distances, gap distance, and particle flight distance. These settings are described in detail in the manufacturer's user's manual. Typically, a gap distance of about 5.5 mm, a macrocarrier flight distance of about 10 mm and a particle flight distance of about 6 to 9 cm is-used. In addition, a screen or baffle may be inserted within the particle flight distance between the stopping screen and the target plate. Such a screen or baffle disturbs the shock wave from the expanding gas thereby reducing damage to the target. In one example, stainless steel screens with an opening of about 100 um is used. Other opening sizes and material composition may be used.
  • The immature embryos or Type I embryogenic callus may be arranged on the target plate in different patterns. Through a series of experiments, optimized patterns were developed for immature embryos. In one optimized pattern, the immature embryos are arranged in a circular pattern, the circle being about 2 cm in diameter. The immature embryos are placed on the periphery of the circle. Approximately 36 immature embryos are placed onto each target plate. Furthermore, the target plate may be angled relative to the microcarrier launch assembly. This ensures maximum saturation of the basipetal portion of the immature embryo by the particle spread. It is the basipetal portion of the immature embryo that gives rise to the embryogenic response.
  • In one example of the bombardment of Type I embryogenic callus, the callus is placed on the periphery of a circle about 1 cm diameter on a nutrient medium. The mechanical settings of the bombardment device may be placed at positions similar or identical to the settings recited above for the bombardment of immature embryos.
  • It should be noted that the target pattern and gun settings are interrelated. In other words, the use. of other mechanical settings on the microprojectile bombardment device can produce other optimal arrangements of the recipient tissue on the target plate. Other combinations of mechanical settings and target patterns are within the scope of the invention.
  • The recombinant DNA molecules of the invention also can include a marker gene to facilitate selection in recombinant plant cells.
  • Examples of markers include resistance to a biocide such as an antibiotic, e.g. kanamycin, hygromycin, chloramphenicol, paramomycin, methotrexate and bleomycin, or a herbicide such as imidazolones, sulfonylureas, glyphosate, phosphinothricin (PPT), glufosinate, or bialaphos. Marker genes are well known in the art. In one embodiment of the invention the selection agent phosphinothricin is used in conjunction with the selectable marker gene known as bar, which encodes for the enzyme phosphinothricin acetyltransferase. This enzyme acetylates the phosphinothricin molecule, thereby rendering it non-toxic to plant cells. The bar gene may be operably linked to a constitutive promoter such as the CaMV 35S promoter; the CaMV 19S promoter; A. tumefaciens promoters such as octopine synthase promoters, mannopine synthase promoters, nopaline synthase promoters, or other opine synthase promoters; ubiquitin promoters, actin promoters, histone promoters and tubulin promoters. Other promoters may also be used. In one embodiment of the present invention, the bar coding sequence is operably linked to the CaMV 35S promoter.
  • Selection of transformed cells in vitro is accomplished by including the selection agent of interest in the medium used to induce and support the establishment of embryogenic callus. Only cells in which the selectable marker is integrated into the chromosome and is expressed, i.e., are transformed, will survive the selection agent. Over time, the cells will grow into an embryogenic callus in the presence of the selection agent eventually reaching a mass sufficient for regeneration of whole, fertile plants. Typically, such embryogenic callus can be maintained for long periods of.time in the presence of selection agent and still retain its ability to produce whole, fertile plants. The minimum time required to obtain an embryogenic callus of sufficient mass under selection pressure can range from about 2 weeks to about 24 weeks, more preferably about 4 weeks to about 20 weeks, most preferably about 8 weeks to about 12 weeks.
  • Transformed cells may also be selected in vitro through visual means. In order to accomplish this, a scorable marker is generally used. Examples of scorable markers would be the regulatory or structural genes controlling anthocyanin biosynthesis, GUS (beta-glucuronidase), luciferase, opine synthetases, thaumatin, beta-galactosidase, unique synthetic epitopes designed for easy detection by ELISA, phycobiliproteins and various fluorigenic substances. In a particular embodiment of the present invention the use is made of coding sequences for the anthocyanin regulatory genes known in the art as C1 and B-Peru (Goff et al., EMBO Journal, 9: 2517, 1990). Such coding sequences, operably linked to one or more of the several constitutive promoters listed above, can be used to isolate transformants on the basis of the red pigmentation of cells transformed with such-genes.
  • Fertile transformed plants may be regenerated from isolated transformed embryogenic callus by several means. In general, the transformed embryogenic callus is transferred to a nutrient medium devoid of an auxin-type phytohormone, or is passaged through a series of nutrient media with diminishing concentrations of phytohormone. Other phytohormones may be used during the regeneration step, such as cytokinins (both natural and synthetic) and gibbetellins. In some instances, inhibitors of phytohormone action may also be used, such as silver nitrate, ancymidol or TIBA. Other amendments to the nutrient medium for regeneration such as activated charcoal and various gelling agents are also known in the art.
  • In one example of the present invention, embryogenic callus was removed from maintenance medium containing PPT after 12 weeks and placed on regeneration medium containing MS basal medium, 3% sucrose, 0.25 mg/L 2,4-D and 5 mg/L benzyladenine. After 2 weeks the embryogenic callus began to regenerate and was transferred to MS basal medium with 3% sucrose. Plantlets are obtained during incubation under light. Such plants may be transferred to a greenhouse environment after sufficient root mass has developed.
  • In another embodiment of the invention, transformed embryogenic callus is transferred from maintenance medium containing phosphinothricin to regeneration medium consisting of MS medium, 3%. sucrose and also containing phosphinothricin. Regeneration under such selective conditions also produces plantlets during incubation under light, which again may be transferred to a greenhouse environment after sufficient root mass has developed.
  • As will be evident to one of skill in the art, now that a method has been provided for the stable transformation of maize according to the claimed method, any gene of interest can be used in the methods of the invention. For example, a maize plant can be engineered to express disease and insect resistance genes, genes conferring nutritional value, genes to confer male and/or female sterility, antifungal, antibacterial or antiviral- genes, and the like. Likewise, the method can be used to transfer any nucleic acid to control gene expression. For example, the DNA to be transferred could encode antisense RNA.
  • The present invention also encompasses the production by the disclosed method of transformed maize plants and progeny containing a gene or genes which encode for and express insecticidal proteins. Such genes may be derived from the genus Bacillus, for example Bacillus thuringiensis. In a particular embodiment of the present invention is the use of the claimed method to produce transformed maize plants containing a gene or genes whose nucleic acid sequence has been altered so as to be optimized for expression in maize. A complete description of the creation of said gene or genes may be found in U.S. Ser. No. 951,715 which is herein incorporated by reference. A summary of that disclosure- is given below.
  • A nucleic acid sequence of interest in the present invention includes one which encodes the production of an insecticidal toxin, preferably a polypeptide sharing substantially the. amino acid sequence of an insecticidal crystal protein toxin normally produced by Bacillus thuringiensis (BT). The synthetic gene may encode a truncated or full-length insecticidal protein (IP) Especially preferred are synthetic nucleic sequences which encode a polypeptide effective against insects of the order Lepidoptera and Coleoptera, and synthetic nucleic acid sequences which encode a polypeptide having an amino acid sequence essentially the same as one of the crystal protein toxins of Bacillus thuringiensis variety kurstaki, HD-1.
  • The present invention provides the use of synthetic nucleic acid sequences to yield high level expression of active insecticidal proteins in maize plants. The synthetic,nucleic acid sequences of the present invention have been modified to resemble a maize gene in terms of codon usage and G+C content. As a result of these modifications, the synthetic nucleic acid sequences of the present invention do not contain the potential processing sites which are present in the native gene. The resulting synthetic nucleic acid sequences (synthetic BT IP coding sequences) and plant transformation vectors containing this synthetic nucleic acid sequence (synthetic BT IP genes) result in surprisingly increased expression of the synthetic BT IP gene, compared to the native BT IP gene, in terms of insecticidal protein production in plants, particularly maize. The high level of expression results in maize cells and plants that exhibit resistance to lepidopteran insects, preferably European Corn Borer and Diatrea saccharalis, the Sugarcane Borer.
  • For example, the maize codon usage table described in Murray et al., Nucleic Acids Research, 17:477 1989, the disclosure of which is incorporated herein by reference, was used to reverse translate the amino acid sequence of the toxin produced by the Bacillus thuringiensis subsp. kurstaki HD-1 cryIA(b) gene, using only the most preferred maize codons. This sequence was subsequently modified to eliminate unwanted restriction endonuclease sites, and to create desired restriction endonuclease sites. These modifications were designed to facilitate cloning of the gene without appreciably altering the codon usage or the maize optimized sequence. During the cloning procedure, in order to facilitate cloning of the gene, other modifications were made in a region that appears especially susceptible to errors induced during cloning by the polymerase chain reaction (PCR).
  • In a preferred embodiment of the present invention, the protein produced by the synthetic nucleic acid sequence of interest is effective against insects of the order Lepidoptera or Coleoptera. In a more preferred embodiment, the polypeptide encoded by the synthetic nucleic acid sequence of interest consists essentially of the full-length or a truncated amino acid sequence of an insecticidal protein normally produced by Bacillus thuringiensis var. kurstaki HD-1. In a particular embodiment, the synthetic DNA sequence encodes a polypeptide consisting essentially of a truncated amino acid sequence of the BT CryIA(b) protein.
  • The present invention also encompasses the use of maize optimized coding sequences encoding other polypeptides, including those of other Bacillus thuringiensis insecticidal polypeptides or insecticidal proteins from other sources. For example, cryIB genes from Bacillus thuringiensis can be maize optimized, and then stably introduced into maize plants. It is also within the scope of this invention that the nucleic acid sequences of interest which encode insecticidal proteins may be either in the native or synthetic forms, optimized for expression in maize, and derived from any species of the genus Bacillus.
  • The insecticidal proteins produced by the nucleic acid sequences of interest in the present invention are expressed in a maize plant in an amount sufficient to control insect pests, i.e. insect controlling amounts. It is recognized that the amount of expression of insecticidal protein in a plant necessary to control insects may vary depending upon species of plant, type of insect, environmental factors and the like. Generally, the insect population will be kept below the economic threshold which varies from plant to plant. For example, to control European corn borer in maize, the economic threshold is 0.5 eggmass/plant which translates to about 10 larvae/plant.
  • In the present invention, the coding sequence of the nucleic acids of interest is a synthetic maize-optimized gene under the control of regulatory elements such as promoters which direct expression of the coding sequence. Such regulatory elements, for example, include monocot or maize and other monocot functional promoters to provide expression of the gene in various parts of the maize plant.
  • The regulatory element may be constitutive. That is, it may promote continuous and stable expression of the gene. Such promoters include but are not limited to the CaMV 35S promoter; the CaMV 19S promoter; A. tumefaciens promoters such as octopine synthase promoters, mannopine synthase promoters, nopaline synthase promoters, or other opine synthase promoters; ubiquitin promoters, actin promoters, histone promoters and tubulin promoters.
  • The regulatory element may also be a tissue-preferential or tissue-specific promoter. The term “tissue-preferred promoter” is used to indicate that a given regulatory DNA sequence will promote a higher level of transcription of an associated structural gene or DNA coding sequence, or of expression of the product of the associated gene as indicated by any conventional RNA or protein assay, or that a given DNA sequence will demonstrate some differential effect; i.e., that the transcription of the associated DNA sequences or the expression of a gene product is greater in some tissue than in all other tissues of the plant. Preferably, the tissue-preferential promoter may direct higher expression of the synthetic gene in leaves, stems, roots and/or pollen than in seed. “Tissue-specific promoter” is used to indicate that a given regulatory DNA sequence will promote transcription of an associated coding DNA sequence essentially entirely in one or more tissues of a plant, or in one type of tissue, e.g. green tissue, while essentially no transcription of that associated coding DNA sequence will occur in all other tissues or types of tissues of the plant. Numerous promoters whose expression are known to vary in a tissue specific manner are known in the art. One such example is the maize phosphoenol pyruvate carboxylase (PEPC), which is green tissue-specific. See, for example, Hudspeth, R.L. and Grula, J. W., Plant Molecular Biology 12:579-589, 1989. Other green tissue-specific promoters include chlorophyll a/b binding protein promoters and RubisCO small subunit promoters.
  • The regulatory element may also be inducible, such as by heat stress, water stress, insect feeding or chemical induction, or may be developmentally regulated.
  • In one preferred nucleic acid of interest, the regulatory element is a pith-preferred promoter isolated from a maize TrpA gene.
  • That is, the promoter.in its native state is operatively associated with a maize tryptophan synthase-alpha subunit gene (hereinafter “TrpA”). The encoded protein has a molecular mass of about 38kD. Together with another alpha subnit and two beta subunits, TrpA forms a multimeric enzyme, tryptophan synthase.
  • Each subunit can operate separately, but they function more efficiently together.
  • The nucleic acids of interest in the present invention also include purified pollen-specific promoters obtainable from a plant calcium-dependent phosphate kinase (CDPK) gene. That is, in its native state, the promoter is operably linked to a plant CDPK gene. In a preferred embodiment, the promoter is isolated from a maize CDPK gene. By “pollen-specific,” it is meant that the expression of an operatively associated structural gene of interest is substantially exclusively (i.e. essentially entirely) in the pollen of a plant, and is negligible in all other plant parts. By “CDPK,” it is meant a plant protein kinase which has a high affinity for calcium, but not calmodulin, and requires calcium, but not calmodulin, for its catalytic activity.
  • In another nucleic acid of interest, the regulatory element is a root-preferential promoter. A complete description of such a root promoter and the methods for finding one may be found in U.S. Ser. No. 508,207 filed Apr. 12, 1990, the relevant parts of which are herein incorporated by reference. Briefly, a root-preferential promoter was isolated from a gene whose cDNA was found by differential screening of a CDNA library from maize. A CDNA clone so obtained was used to isolate a homologous genomic clone from maize. The protein encoded by the isolated clone was identified as a metallothionein-like protein.
  • Maize is easily hybridized because of the physical distance between the tassel (male part) and the ear (female part). The method of hybridization first involves the development of inbred lines. Inbred lines are maize plants that are essentially the same genetically from generation to generation. Inbreds are produced by taking the pollen from one maize plant and transferring the pollen to the silk of a receptive maize ear of that same plant. Selections for uniformity and agronomic performance are made and the process is repeated until the.seeds from the ears of the plants produce genetically the same plants and. the line is pure. A hybrid maize plant is produced by crossing one elite inbred maize plant with one or more other, genetically different and diverse, inbred maize plant. The crossing consists of taking the pollen from one inbred elite maize plant and transferring the pollen to the silk of a receptive ear of the other elite inbred maize plant. The seed from crossing of two inbreds is a first generation hybrid and is called a F1. The F1 of commercially valuable inbreds have better yields, standability, and improvement in other important characteristics than either of the parents. This phenomenon is called hybrid vigor.
  • In the present invention, commercially-valuable inbred lines of maize are directly transformed through the disclosed methods of delivering nucleic acid sequences of interest to either immature zygotic embryos obtained from such lines or Type I embryogenic callus derived from immature zygotic embryos of such lines. The ability to directly transform maize lines of commercial value is a distinct advantage of the claimed invention in that the generations of backcrossing required when the starting material is not commercially valuable can be avoided, thereby reducing the time and cost of commercialization. Alternatively, the present invention also discloses the direct transformation of hybrids of inbred lines using the claimed methods.
  • Many hybrid crosses have been successfully made using the transformed, commercially-valuable plants of the claimed invention. For example, the transformed genotype CG00526 of Example 2, below, has been crossed to genotypes CG00689, CG00716, CG00661, CG00642, and LH82 thereby creating hybrids possessing insecticidal activity.
  • Using the methods of the present invention any hybrid expressing a gene of interest can be created by transforming an inbred line with the gene of interest and using such transformed line to create the hybrid. A transformed hybrid may also be obtained according to the present invention by directly transforming either immature zygotic embryos obtained from said hybrid plant or by transforming Type I embryogenic callus derived from immature zygotic embryos obtained from said hybrid plant.
  • In another embodiment of the claimed invention, it is also possible to produce maize plants that have an altered phenotype of anthocyanin pigmentation. This can be accomplished through the use of the disclosed chimeric genes for the constitutive promotion of the genes known as C1 and B-Peru. That activation of the biosynthetic pathway for anthocyanin can be achieved in this way in embryogenic callus was reported by Goff et al., EMBO Journal, 9: 2517-2522, 1990. In the present invention, the above said genes were used to produce plants and progeny according to the claimed method whose color phenotype was altered.
  • Commercially-valuable maize genotypes having altered-color phenotype may have benefit to the process of plant breeding. For example, the use of the monoploid inducing gene known as ig (Kermicle, Science 166:1422-1424, 1969) can be used to create a haploid having a paternal nuclear constitution. Monoploid inducers creating a haploid having a maternal nuclear constitution ate also known (for example, Coe, The American Naturalist, XCIII: 381-382, 1959). Because of the low frequency of such an event, it would be advantageous to have an easily screened color phenotype which would allow the identification of the haploids. By using the claimed method and genes of interest, it is possible to obtain a transformed maize line having pigmented seeds, which can be used with a monoploid inducing line. Haploid seed can then be identified by either the presence or absence of seed pigmentation, depending upon the genotypes and crossing methods used.
  • Since a variety of altered color phenotypes can be produced by the present invention, examples of which are described below, it is further envisioned that other uses in plant breeding may be found for the claimed plants. As another example of such utility, it is possible to link operably, molecularly, biochemically or genetically, or any combination thereof, the expression of the altered color phenotype with the expression of the insecticidal activity produced by transformation of maize according to the claimed methods. Such a link would allow rapid, visual identification of plants within a segregating population of plants and possesing the gene or gene products. Linkages of the altered color phenotype and genotype to other traits of agronomic interest are also envisioned. The ability to perform such identification would translate intq reduced costs and time for the plant breeder.
  • EXAMPLES
  • The following examples further describe the materials and methods used in carrying out the invention and the subsequent results.
  • They are offered by way of illustration, and their recitation should not be considered as a limitation of the claimed invention.
  • Example 1
  • Bioassay of Transformed Maize for Insecticidal Activity and Quantitation of an Insecticidal Protein.
  • Transformed plants were assayed for insecticidal activity and the presence of a BT protein resulting from the expression of the maize-optimized coding sequence of a synthetic BT gene. The procedure is similar for any maize plant transformed with a BT gene but is described here using as an example a cryIA(b) gene, its expressed product, and resistance to European corn borer.
  • Insecticidal activity was determined by insect bioassay. One to four 4 cm sections are cut from an extended leaf of a transformed maize plant. Each leaf piece is placed on a moistened filter disc in a 50×9 mm petri dish. Five neonate European corn borer larvae are placed on each leaf piece. Since each plant is sampled multiple times this makes a total of 5-20 larvae per plant. The petri dishes are incubated at 29.5° C. and leaf feeding damage and mortality data are scored at 24, 48, and 72 hours.
  • Quantitative determination of a cryIA(b) IP in the leaves of transgenic plants is performed using enzyme-linked immunosorbant assays (ELISA) as disclosed in Clark M F, Lister R M, Bar-Joseph M: ELISA Techniques. In: Weissbach A, Weissbach H (eds) Methods in Enzymology 118:742-766, Academic Press, Florida (1986).
  • Immunoaffinity purified polyclonal rabbit and goat antibodies specific for the B. thuringiensis subsp. kurstaki IP were used to determine ng IP per mg soluble protein from crude extracts of leaf samples. The sensitivity of the double sandwich ELISA is 1-5 ng IP per mg soluble protein using 50 ug of total protein per ELISA microtiter dish well. Corn extracts were made by grinding leaf tissue in gauze lined plastic bags using a hand held ball-bearing homogenizer (AGDIA, Elkart IN.) in the presence of extraction buffer (50 mM Na2CO3 pH 9.5, 100 mM NaCl, 0.05% Triton, 0.05% Tween, 1 mM PMSF and 1 pM leupeptin). Protein determination was performed using the Bio-Rad (Richmond, CA) protein assay.
  • Example 2
  • Transformation of the CG00526 Genotype of Maize by Direct Bombarding of Immature Zygotic Embryos and Isolation of Transformed Callus with the Use of Phosphinothricin as a selection agent.
  • Immature embryos for experiment KC-65 were obtained approximately 14 days after self-pollination. The immature zygotic embryos were divided among different target plates containing medium capable of inducing and supporting embryogenic callus formation at 36 immature embryos per plate. The immature zygotic embryos were bombarded with a mixture of the plasmids pCIB3064 and pCIB4431 using the PDS-1000/He device from DuPont. The plasmids were precipitated onto 1 um gold particles essentially according to the published procedure from DuPont, as described.above. Each target plate was shot one-time with the plasmid and gold preparation. Since the plasmid pCIB3064 contained a chimeric gene coding for resistance to phosphinothricin this substance was used to select transformed cells in vitro. This selection was applied at 3 mg/L one day after bombardment and maintained for a total of 12 weeks. The embryogenic callus so obtained was regenerated in the absence of the selection agent phosphinothricin. Plants were obtained from one isolated line of embryogenic callus and given the Event Number 176. All plants were tested by the chlorophenol red (CR) test for resistance to PPT as described in U.S. patent application Ser. No. 759,243, filed Sep. 13, 1991, the relevant portions of which are hereby incorporated herein by reference. This assay utilizes a pH sensitive indicator dye to show which cells are growing in the presence of PPT. Cells which grow produce a pH change in the media and turn the indicator yellow (from red). Plants expressing the resistance gene to PPT are easily seen in this test. Of the 38 plants regenerated for Event Number 176, eight were positive in this test and 30 were negative. Plants positive by the CR test were assayed by PCR for the presence of the synthetic BT gene. Of the eight positive plants from the CR test, 5 were positive for the presence of the synthetic BT gene, 2 were negative and 1 died during propagation. These five remaining plants were bioassayed and found to be resistant to European Corn Borer. DNA was isolated from plant #11 using standard techniques and analysed by Southern blot analysis. It was found to contain sequences which hybridize with probes generated from the synthetic cryIA(b) gene and with a probe generated from the PAT gene. These results showed integration of these genes into the genome of maize. Plant 11 was shown by ELISA to contain 2,195 ng BT protein per mg soluble protein in the leaf tissue, consistent with the use of the leaf-specific promoter from PEPC operably linked to a synthetic BT gene. Plants resistant to European Corn Borer and expressing the introduced BT gene are transformed.
  • Example 3
  • Transformation of the Hi II genotype of Maize by Direct Bombarding of Immature Zygotic Embryos and Isolation of Transformed Callus without the Use of a Selection Agent.
  • Ear number ED42 was self-pollinated and immature zygotic embryos were obtained approximately 10 days later. Two hundred and eighty eight immature zygotic embryos were divided among 7 different target plates containing a medium capable of inducing and supporting the formation of embryogenic callus. After two days, the immature zygotic embryos were transferred to the same medium but containing 12% sucrose. After 5 hours, the immature zygotic embryos were bombarded with a mixture of the plasmids pCIB3089, pCIB4430, pCIB4433, pCIB4436 using the PDS-1000/He device from DuPont. The plasmids were precipitated onto 1 um gold particles essentially according to the published procedure from DuPont, as described above. The particles were delivered using burst pressures of 450, 650 and 900 psi of helium. Each target plate was shot twice with the plasmid and gold particle preparation. After overnight incubation, the immature embryos were transferred to fresh maintenance medium containing 2% sucrose. Since the plasmids pCIB3089 and pCIB4436 contain the C1 and B-Peru genes which regulate anthocyanin production, the appearance of red, multicellular sectors on the developing embryogenic callus was used to select and isolate transformed cells, eventually obtaining a homogeneous callus line. Embryogenic callus was regenerated in both the absence and presence of the selection agent phosphinothricin, resistance to which was conferred by a chimeric gene present in plasmid pCIB4433. Plants were obtained from a total of nine isolated embryogenic callus lines and were given the Event Numbers 197, 198, 208, 211, 219, 255, 261, 281 and 284. Leaf tissue from plants from each event were assayed for resistance to European Corn Borer. Plants from Event Numbers 208 and 211 were susceptible to European Corn Borer whereas plants from Event Numbers 197, 198, 219, 255, and 261 were resistant. All the plants that were resistant to European Corn Borer also expressed the introduced, leaf-specific PEPC-promoted synthetic BT gene as evidenced by thd detection of BT protein using an ELISA assay.
  • Plants resistant to European Corn Borer and expressing the introduced BT gene are transformed.
  • Example 4
  • Transformation of the Hi II Genotype of Maize by Direct Bombarding of Immature Zygotic Embryos and Isolation of Transformed Callus with the Use of Phosphinothricin as a Selection Agent.
  • Ear number ED47 was self-pollinated and immature zygotic embryos were obtained approximately 10 days later. Approximately two hundred and sixty immature zygotic embryos were divided among 8 different target plates containing a medium capable of inducing and supporting the formation of embryogenic callus. After two days, the immature zygotic embryos were transferred to the same medium but containing 12% sucrose. After 5 hours, the immature zygotic embryos were bombarded with a mixture of the plasmids pCIB3089, pCIB4430, pCIB4433, pCIB4436 using the PDS-1000/He device from DuPont. The plasmids were precipitated onto 1 um gold particles essentially according to the published procedure from DuPont, as described above. The particles were delivered using a burst pressure of 900 psi of helium. Each target plate was shot twice with the plasmid and gold particle preparation. After overnight incubation, -the immature embryos were transferred to fresh maintenance medium containing 2% sucrose. Since the plasmid pCIB4433 contained a chimeric gene coding for resistance to phosphinothricin this substance was used to select transformed cells in vitro. The selection agent was applied at 10 mg/L 14 days after gene delivery and increased to 20-40 mg/L after approximately one month. The embryogenic callus so obtained was regenerated in the presence of the selection agent phosphinothricin. Plants were obtained from a total of eleven isolated embryogenic callus lines and were given the Event Numbers 220, 221, 222, 223, 225, 230, 231, 232, 233, 269, 274. Plants from each event were assayed for resistance to European Corn Borer. Leaf tissue of plants from Event Numbers 220, 221, 222, 223, 225, 231 and 233 were resistant. All the plants that were resistant to European Corn Borer also expressed the introduced, leaf-specific PEPC-promoted synthetic BT gene as evidenced by the detection of BT protein using an ELISA assay. Plants resistant to European Corn Borer and expressing the introduced BT gene are transformed. Plants from Event Numbers 230, 232, 269 and 274 were not completely tested.
  • Example 5
  • Transformation of the CG00526 Genotype of Maize by Bombarding of Type I Callus Derived from Immature Zygotic Embryos and Isolation of Transformed Callus with the Use of Phosphinothricin as a Selection Agent.
  • Type I callus was obtained from immature zygotic embryos using standard culture techniques. For gene delivery, approximately 300 mg of the Type I callus was prepared by chopping with a scalpel blade, rinsing 3 times with standard culture media containing 18% sucrose and immediately placed onto semi-solid culture medium again containing 18% sucrose. After approximately 4 hours, the tissue was bombarded using the PDS-1000/He Biolistic device from DuPont. The plasmids pCIB4430 and pCIB4433 were precipitated onto 1 um gold particles using the standard protocol from DuPont. Approximately 16 hours after gene delivery the callus was transferred to standard culture medium containing 2% sucrose and 10 mg/L phosphinothricin as Basta. The callus was subcultured on selection for 8 weeks, after which surviving and growing callus was transferred to standard regeneration medium for the production of plants.
  • Example 6
  • Transformation of the LH51 Genotype of Maize by Bombarding of Type I Callus Derived from Immature zygotic embryos and Isolation of Transformed Callus with the Use of Phosphinothricin as a Selection Agent.
  • Type I callus was obtained from immature zygotic embryos using standard culture techniques. For gene delivery, approximately 300 mg of the Type I callus was prepared by chopping with a scalpel blade, rinsing 3 times with standard culture media containing 12% sucrose and immediately placed onto semi-solid culture medium again containing 12% sucrose. After approximately 4 hours, the tissue was bombarded using the PDS-1000/He Biolistic device from DuPont. The plasmids pCIB4430 and pCIB4433 were precipitated onto 1 um gold particles using essentially the standard protocol from DuPont as described above. Approximately 16 hours after gene delivery the callus was transferred to standard culture medium containing 2% sucrose and 1 mg/L phosphinothricin as Basta. The callus was subcultured on selection for 8 weeks, after which surviving and growing callus was transferred to standard regeneration medium for the production of plants.
  • Example 7
  • Transformation of the CG00526 Genotype of Maize by Direct Bombarding of Immature Zygotic Embryos and Isolation of Transformed Callus with the Use of Phosphinothricin as a Selection Agent.
  • Ear numbers JS21, JS22, JS23, JS24 and JS25 were self-pollinated and immature zygotic embryos were obtained approximately 10 days later. Approximately eight hundred and forty immature zygotic embryos were divided among 14 different target plates containing a medium capable of inducing and supporting the formation of embryogenic callus. The immature zygotic embryos were transferred immediately to the same medium but containing 12% sucrose. After 5 hours, the immature zygotic embryos were bombarded with a mixture of the plasmids pCIB3089, pCIB4433, pCIB4436 using the PDS-1000/He device from DuPont. The plasmids were precipitated onto 1 um gold particles essentially according to the published procedure from DuPont, as described above. The particles were delivered using a burst pressure of 1550 psi of helium. Each target plate was shot twice with the plasmid and gold particle preparation. Since the plasmid pCIB4433 contained a chimeric gene coding for resistance to phosphinothricin this substance was used to select transformed cells in vitro. The selection agent was applied at 10 mg/L on the day of gene delivery and increased to 40 mg/L after approximately one month. The embryogenic callus so obtained was regenerated in the presence of the selection agent phosphinothricin. Plants were obtained from a total of eight isolated embryogenic callus lines and were given the Event Numbers 187, 188, 191, 192, 193, 196, 228 and 229. Plants from each event were assayed for resistance to European Corn Borer. Plants from Event Numbers 191 and 193 exhibited insect resistance in the pith in accordance with the use of the pith-preferred synthetic BT construct. All the plants that were resistant to European Corn Borer also expressed the introduced chimeric BT gene as evidenced by the detection of BT protein in the pith using an ELISA assay. Plants resistant to European Corn Borer and expressing the introduced BT gene are transformed.
  • Example 8
  • Transformation of the (H99xFR16)xPa9l Genotype of Maize by Direct Bombarding of Immature Zygotic Embryos and Isolation of Transformed Callus with the Use of Phosphinothricin as a Selection Agent.
  • Ear numbers GP5 and JS26 were self-pollinated and immature zygotic embryos were obtained approximately 10 days later. Approximately three hundred and thirty immature zygotic embryos were divided among 5 different target-plates containing a medium capable of inducing and supporting the formation of embryogenic callus. After two days the immature zygotic embryos were transferred to the same medium but containing 12% sucrose. After approximately 5 hours, the immature zygotic embryos were bombarded with a mixture of the plasmids pCIB3089, pCIB4430, pCIB4433, pCIB4436 using the PDS-1000/He device from DuPont. The plasmids were precipitated onto 1 um gold particles essentially according to the published procedure from DuPont, as described above. The particles were delivered using a burst pressure of 1300 psi of helium. Each target plate was shot twice with the plasmid and gold particle preparation. Since the plasmid pCIB4433 contained a chimeric gene coding for resistance to phosphinothricin this substance was used to select transformed cells in vitro. The selection agent was applied at 10 mg/L 3 weeks after the day of gene delivery. The embryogenic callus so obtained was regenerated. Plants were obtained from three isolated embryogenic callus lines and were given the Event Numbers 242, 247 and 260. Plants from each event were assayed for resistance to European Corn Borer. Plants from Event Numbers 247 and 260 exhibited insect resistance indicating that they were transformed.
  • Example 9
  • Transformation of the CGO0526 Genotype of Maize by Direct Bombarding of Immature zygotic embryos and Isolation of Transformed Callus with the Use of Phosphinothricin as a Selection Agent.
  • Immature zygotic embryos for. the experiment KM-124 were obtained approximately 14 days after self-pollination. Approximately one hundred and five immature zygotic embryos were divided among 4 different target plates containing a medium capable of inducing and supporting the formation of embryogenic callus. The immature zygotic embryos were bombarded with a mixture of the plasmids pCIB4421 and pCIB4433 using the PDS-1000/He device from DuPont.
  • The plasmids were-precipitated onto 1 um gold particles essentially according to the published procedure from DuPont, as described above. The particles were delivered using a burst pressure of 1550 psi of helium. Each target plate was shot once with the plasmid and gold particle preparation. Since the plasmid pCIB4433 contained a chimeric gene coding for resistance to phosphinothricin this substance was used, as Basta, to select transformed cells in vitro. The selection agent was applied at 5 mg/L one day after gene delivery and maintained for a total of 12 weeks. The embryogenic callus so obtained was regenerated in the absence of the selection agent phosphinothricin. Plants were obtained from one isolated embryogenic callus line and was given the Event Number 268. Plants were assayed for resistance to European Corn Borer. One of the 5 plants obtained is resistant to European Corn Borer and is transformed.
  • Example 10
  • Color Phenotypes Exhibited by Plants Transformed with the C1 and B-Peru Coding Sequences According to the Claimed Methods
  • Both genotypes Hi II and CG00526 were transformed with the C1 and B-Peru chimeric genes recited above in FIGS. 2 and 7. A variety of stably expressed altered color phenotypes were obtained, a partial listing of which -appears in Table IV, below.
    TABLE IV
    BT Event Number Color Phenotype
    197 Red roots, red anthers
    208 Red roots
    211 Red roots
    213 Red stripe shoot
    204 Red anthers, pink silks
    210 Red stripe shoot, red root, red anther, red
    silk, red embryo
    239 Red shoot, red root, red silk, normal embryo
    207 Red anthers, red silks
  • All publications and patent applications mentioned in this specification are indicative of the level of skill of those skilled in the art to which this invention pertains. All publications and patent applications are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
  • Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims.

Claims (34)

1-82. (canceled)
82. A fertile transgenic Zea mays plant comprising a preselected DNA sequence encoding a Bacillus thuringiensis endotoxin, wherein the preselected DNA sequence is adjusted to be more efficiently expressed in maize than the native B. thuringiensis DNA sequence encoding said endotoxin, and wherein said preselected DNA is heritable.
83. The transgenic Zea mays plant of claim 82 wherein the preselected DNA sequence comprises an increased G+C content of the degenerate third base of the codons.
84. The transgenic Zea mays plant of claim 82 wherein the preselected DNA sequence comprises a sequence encoding the HD73 endotoxin of Bacillus thuringiensis.
85. A seed produced by the transgenic Zea mays plant of claim 82, 83 or 84 which comprises said preselected DNA sequence.
86. The transgenic Zea mays plant of claim 82 wherein the preselected DNA sequence encodes a truncated Bacillus thuringiensis endotoxin.
87. The transgenic Zea mays plant of claim 82 wherein the preselected DNA sequence comprises a promoter.
88. A fertile inbred transgenic Zea mays plant comprising a preselected DNA sequence encoding a Bacillus thuringiensis endotoxin, wherein the preselected DNA sequence is adjusted to be more efficiently expressed in maize than the native B. thuringiensis DNA sequence encoding said endotoxin and wherein the preselected DNA sequence is heritable.
89. A fertile hybrid transgenic Zea mays plant comprising a preselected DNA sequence encoding a Bacillus thuringiensis endotoxin, wherein the preselected DNA sequence is adjusted to be more efficiently expressed in maize than the native B. thuringiensis DNA sequence encoding said endotoxin, and wherein the preselected DNA sequence is heritable.
90. A fertile transgenic Zea mays plant comprising a preselected heritable DNA sequence encoding a Bacillus thuringiensis endotoxin, wherein the preselected DNA sequence is adjusted to be more efficiently expressed in maize than the native B. thuringiensis DNA sequence encoding said endotoxin, and wherein the preselected DNA sequence further comprises a selectable marker gene or a reporter gene.
91. The transgenic Zea mays plant of claim 90 wherein the preselected DNA sequence comprises a sequence encoding the HD73 endotoxin of Bacillus thuringiensis.
92. The transgenic Zea mays plant of claim 90 wherein the preselected DNA sequence comprises a sequence encoding the HD1 endotoxin of Bacillus thuringiensis.
93. A seed produced by the transgenic Zea mays plant of claim 90, 91 or 92 which comprises said preselected DNA sequence.
94. The transgenic Zea mays plant of claim 90 wherein the DNA sequence encodes a truncated Bacillus thuringiensis endotoxin.
95. The transgenic Zea mays plant of claim 90 wherein the preselected DNA sequence further comprises a promoter operably linked to said DNA sequence encoding said endotoxin and a promoter operably linked to said selectable marker gene.
96. A fertile inbred transgenic Zea mays plant comprising a preselected heritable DNA sequence encoding a Bacillus thuringiensis endotoxin, wherein the preselected DNA sequence is adjusted to be more efficiently expressed in maize than the native B. thuringiensis DNA sequence encoding said endotoxin, and wherein the preselected DNA sequence further comprises a selectable marker gene or a reporter gene.
97. A fertile hybrid transgenic Zea mays plant comprising a preselected heritable DNA sequence encoding a Bacillus thuringiensis endotoxin, wherein the preselected DNA sequence is adjusted to be more efficiently expressed in maize than the native B. thuringiensis DNA sequence encoding said endotoxin, and wherein the preselected DNA sequence further comprises a selectable marker gene or a reporter gene.
98. The transgenic Zea mays plant of claim 90 wherein the selectable marker gene confers resistance or tolerance to a compound selected from the group consisting of hygromycin, sethoxydim, haloxyfop, glyphosate, methotrexate, imidazoline, sulfonylurea, triazolopyrimidine, s-triazine, bromoxynil, phosphinothricin, kanamycin, G418, 2,2-dichloropropionic acid and neomycin.
99. The transgenic plant of claim 98 wherein the compound is phosphinothricin.
100. The transgenic plant of claim 98 wherein the compound is glyphosate.
101. The transgenic plant of claim 98 wherein the compound is kanamycin.
102. The transgenic plant of claim 98 wherein the compound is hygromycin.
103. The transgenic plant of claim 90 wherein the DNA encoding the Bacillus thuringiensis endotoxin is fused in frame with said selectable marker or reporter gene.
104. The inbred transgenic plant of claim 96 wherein the DNA encodes a truncated Bacillus thuringiensis endotoxin.
105. The hybrid transgenic plant of claim 99 wherein the DNA encodes a truncated Bacillus thuringiensis endotoxin.
106. The transgenic plant of claim 86, 104 or 105 wherein the truncated Bacillus thuringiensis endotoxin comprises about the N-terminal 50% of the endotoxin.
107. The transgenic plant of claim 82 or 90 wherein the preselected DNA further encodes a protease inhibitor.
108. The transgenic plant of claim 87 or 95 wherein the preselected DNA sequence further comprises the maize AdhIS first intron or the maize Shrunken-2 first intron positioned between the promoter and the DNA encoding said endotoxin.
109. The transgenic plant of claim 87 or 95 wherein the preselected DNA sequence further comprises a manopine synthase promoter, a nopaline synthase promoter or an octopine synthase promoter.
110. The transgenic plant of claim 87 or 95 wherein the promoter is the CaMV 35S or 19S promoter.
111. A population of plants obtained by breeding the transgenic plants of claim 82 or 95 wherein the preselected DNA sequence is transmitted by Mendelian inheritance through both male and female parent plants.
112. An inbred insect-resistant transgenic Zea mays plant prepared by a process comprising:
(a) crossing a fertile transgenic Zea mays plant comprising a preselected DNA sequence encoding a Bacillus thuringiensis endotoxin, wherein the preselected DNA sequence is adjusted to be more efficiently expressed in maize than the B. thuringiensis DNA sequence encoding said endotoxin, and wherein said DNA sequence is heritable, with a member of a second inbred Zea mays line;
(b) recovering insect-resistant transgenic progeny plants from said cross;
(c) back-crossing one of the transgenic progeny plants with a member of said second inbred line;
(d) recovering insect-resistant transgenic progeny plants from said cross; and
(e) repeating steps (b) and (c) to obtain said inbred plant.
113. The inbred transgenic Zea mays plant of claim 112 wherein said preselected DNA sequence encodes a truncated Bacillus thuringiensis endotoxin.
114. A transgenic insect-resistant hybrid plant prepared by crossing the inbred plant of claim 112 or 113 with an inbred Zea mays line, and recovering said hybrid plant.
US11/071,896 1990-08-24 2005-03-02 Method of producing transgenic maize using direct transformation of commercially important genotypes Abandoned US20060117407A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/071,896 US20060117407A1 (en) 1990-08-24 2005-03-02 Method of producing transgenic maize using direct transformation of commercially important genotypes

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US57310590A 1990-08-24 1990-08-24
US65943391A 1991-02-25 1991-02-25
US77202791A 1991-10-04 1991-10-04
US07/951,715 US5625136A (en) 1991-10-04 1992-09-25 Synthetic DNA sequence having enhanced insecticidal activity in maize
US837493A 1993-01-25 1993-01-25
US08/438,666 US6403865B1 (en) 1990-08-24 1995-05-10 Method of producing transgenic maize using direct transformation of commercially important genotypes
US10/136,998 US20030237117A1 (en) 1990-08-24 2002-04-30 Method of producing transgenic maize using direct transformation of commercially important genotypes
US11/071,896 US20060117407A1 (en) 1990-08-24 2005-03-02 Method of producing transgenic maize using direct transformation of commercially important genotypes

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/136,998 Continuation US20030237117A1 (en) 1990-08-24 2002-04-30 Method of producing transgenic maize using direct transformation of commercially important genotypes

Publications (1)

Publication Number Publication Date
US20060117407A1 true US20060117407A1 (en) 2006-06-01

Family

ID=27533276

Family Applications (3)

Application Number Title Priority Date Filing Date
US08/438,666 Expired - Lifetime US6403865B1 (en) 1990-08-24 1995-05-10 Method of producing transgenic maize using direct transformation of commercially important genotypes
US10/136,998 Abandoned US20030237117A1 (en) 1990-08-24 2002-04-30 Method of producing transgenic maize using direct transformation of commercially important genotypes
US11/071,896 Abandoned US20060117407A1 (en) 1990-08-24 2005-03-02 Method of producing transgenic maize using direct transformation of commercially important genotypes

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US08/438,666 Expired - Lifetime US6403865B1 (en) 1990-08-24 1995-05-10 Method of producing transgenic maize using direct transformation of commercially important genotypes
US10/136,998 Abandoned US20030237117A1 (en) 1990-08-24 2002-04-30 Method of producing transgenic maize using direct transformation of commercially important genotypes

Country Status (1)

Country Link
US (3) US6403865B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12484581B2 (en) 2019-09-12 2025-12-02 Nihon Nohyaku Co., Ltd. Agricultural or horticultural insecticide or animal ectoparasite or endoparasite control agent each comprising a condensed heterocyclic compound having a substituted cyclopropane-oxadiazole group or a salt thereof as active ingredient, and method for using the insecticide or the control agent
US12486272B2 (en) 2019-09-12 2025-12-02 Nihon Nohyaku Co., Ltd. Agricultural or horticultural insecticide or animal ectoparasite or endoparasite control agent each comprising an imidazopyridazine compound or a salt thereof as active ingredient, and method for using the insecticide or the control agent
US12516062B2 (en) 2019-09-12 2026-01-06 Nihon Nohyaku Co., Ltd. Agricultural or horticultural insecticide or animal ectoparasite or endoparasite control agent each comprising an imidazopyridazine compound having a substituted cyclopropane-oxadiazole group or a salt thereof as active ingredient, and method for using the insecticide or the control agent

Families Citing this family (173)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1103616A3 (en) 1989-02-24 2001-06-27 Monsanto Company Synthetic plant genes and method for preparation
UA48104C2 (en) * 1991-10-04 2002-08-15 Новартіс Аг Dna fragment including sequence that codes an insecticide protein with optimization for corn, dna fragment providing directed preferable for the stem core expression of the structural gene of the plant related to it, dna fragment providing specific for the pollen expression of related to it structural gene in the plant, recombinant dna molecule, method for obtaining a coding sequence of the insecticide protein optimized for corn, method of corn plants protection at least against one pest insect
US7402731B2 (en) * 2001-02-09 2008-07-22 Monsanto Technology Llc Identification of seeds or plants using phenotypic markers
AU2003219806B8 (en) * 2002-02-20 2011-01-27 J.R. Simplot Company Precise breeding
US7534934B2 (en) * 2002-02-20 2009-05-19 J.R. Simplot Company Precise breeding
US7078234B2 (en) 2002-12-18 2006-07-18 Monsanto Technology Llc Maize embryo-specific promoter compositions and methods for use thereof
AU2004225483B2 (en) 2003-03-28 2009-07-23 Monsanto Technology, Llc Novel plant promoters for use in early seed development
EP1921152A1 (en) 2003-05-05 2008-05-14 Monsanto Technology, LLC Transgenic plants with glycine-betaine specific promoter
PT2343364T (en) 2003-08-25 2017-01-02 Monsanto Technology Llc Tubulin regulatory elements for use in plants
WO2005033319A2 (en) 2003-10-02 2005-04-14 Monsanto Technology Llc Stacking crop improvement traits in transgenic plants
US7371848B2 (en) 2004-01-20 2008-05-13 Monsanto Technology Llc Chimeric promoters comprising a caulimovirus promoter enhancer for use in plants
US7683237B2 (en) 2004-02-10 2010-03-23 Monsanto Technology Llc Maize seed with synergistically enhanced lysine content
ES2368721T5 (en) 2004-03-10 2021-05-06 Monsanto Technology Llc Herbicidal compositions containing N-phosphonomethylglycine and an auxin herbicide
EP1788861B1 (en) 2004-08-24 2017-04-12 Monsanto Technology, LLC Adenylate translocator protein gene non-coding regulatory elements for use in plants
WO2006031779A2 (en) 2004-09-14 2006-03-23 Monsanto Technology Llc Promoter molecules for use in plants
US8314290B2 (en) 2004-12-21 2012-11-20 Monsanto Technology Llc Temporal regulation of gene expression by MicroRNAs
US20060200878A1 (en) 2004-12-21 2006-09-07 Linda Lutfiyya Recombinant DNA constructs and methods for controlling gene expression
WO2006073727A2 (en) 2004-12-21 2006-07-13 Monsanto Technology, Llc Recombinant dna constructs and methods for controlling gene expression
US9121028B2 (en) * 2005-09-09 2015-09-01 Monsanto Technology Llc Selective gene expression in plants
US20070079396A1 (en) 2005-10-03 2007-04-05 Malvar Thomas M Transgenic plant seed with increased lysine
WO2007047016A2 (en) 2005-10-13 2007-04-26 Monsanto Technology, Llc Methods for producing hybrid seed
WO2007095469A2 (en) 2006-02-10 2007-08-23 Monsanto Technology Llc Identification and use of target genes for control of plant parasitic nematodes
CN101421406B (en) 2006-02-13 2016-08-31 孟山都技术有限公司 For producing nucleic acid construct and the method that the seed oil of change forms
AU2007214547B2 (en) 2006-02-13 2012-09-20 Monsanto Technology Llc Selecting and stabilizing dsRNA constructs
EP1984510B1 (en) 2006-02-17 2015-04-08 Monsanto Technology LLC Chimeric regulatory sequences comprising introns from dicotyledons for plant gene expression
EP2316958B1 (en) 2006-05-12 2015-08-19 Monsanto Technology LLC Methods and compositions for obtaining marker-free transgenic plants
CN107012246B (en) 2006-05-25 2021-10-26 孟山都技术有限公司 Soybean disease resistance quantitative trait locus and identification method of composition thereof
US7855326B2 (en) 2006-06-06 2010-12-21 Monsanto Technology Llc Methods for weed control using plants having dicamba-degrading enzymatic activity
BRPI0716748A2 (en) 2006-08-15 2013-09-17 Monsanto Technology Llc Plant breeding compositions and methods using high density marker information.
WO2008027592A2 (en) 2006-08-31 2008-03-06 Monsanto Technology, Llc Phased small rnas
CL2007002532A1 (en) * 2006-08-31 2008-01-11 Monsanto Technology Llc Soc Organizada Bajo Las Leyes Del Estado De Delaware Procedure to identify genes that confer improved traits of a plant population.
CN101802215A (en) 2006-10-12 2010-08-11 孟山都技术有限公司 Plant microRNAs and methods of use thereof
BRPI0717640A2 (en) 2006-10-16 2013-11-12 Monsato Technology Llc PROCESS AND COMPOSITIONS FOR INCREASING PLANT HEALTH
US7939721B2 (en) 2006-10-25 2011-05-10 Monsanto Technology Llc Cropping systems for managing weeds
WO2008073877A2 (en) 2006-12-08 2008-06-19 Pioneer Hi-Bred International, Inc. Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
EP2115141A4 (en) 2007-02-20 2010-08-04 Monsanto Technology Llc INVERTEBRA MICRO-RNA
US7838729B2 (en) 2007-02-26 2010-11-23 Monsanto Technology Llc Chloroplast transit peptides for efficient targeting of DMO and uses thereof
US8609936B2 (en) 2007-04-27 2013-12-17 Monsanto Technology Llc Hemipteran-and coleopteran active toxin proteins from Bacillus thuringiensis
CL2008001682A1 (en) 2007-06-08 2008-12-12 Monsanto Technology Llc Methods for plant improvement through the use of direct nucleic acid sequence information.
WO2009076778A1 (en) 2007-11-27 2009-06-25 Medicago Inc. Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
EP2735619A3 (en) 2007-08-29 2014-08-13 Monsanto Technology LLC Methods and compositions for breeding for preferred traits associated with Goss' Wilt resistance in plants
WO2009049045A1 (en) * 2007-10-09 2009-04-16 Athenix Corporation Computational methods for synthetic gene design
US8097712B2 (en) 2007-11-07 2012-01-17 Beelogics Inc. Compositions for conferring tolerance to viral disease in social insects, and the use thereof
EA034733B1 (en) 2008-01-21 2020-03-13 Медикаго Инк. Nucleic acid for increased expression of hemagglutinin of influenza virus in a plant and use thereof
WO2009146015A2 (en) * 2008-03-31 2009-12-03 Ceres, Inc. Promoter, promoter control elements, and combinations, and uses thereof
SI2262896T1 (en) 2008-04-07 2014-05-30 Monsanto Technology Llc Plant regulatory elements and uses thereof
WO2010002984A1 (en) 2008-07-01 2010-01-07 Monsanto Technology, Llc Recombinant dna constructs and methods for modulating expression of a target gene
US7868688B2 (en) * 2008-12-30 2011-01-11 Cosmic Circuits Private Limited Leakage independent very low bandwith current filter
US20120277117A1 (en) 2009-02-27 2012-11-01 Adel Zayed Hydroponic apparatus and methods of use
CN102428187A (en) 2009-04-20 2012-04-25 孟山都技术公司 Multiple Virus Resistance In Plants
BRPI1015053A2 (en) 2009-06-24 2019-07-09 Medicago Inc chimeric influenza virus-like particles comprising hemagglutinin
US20120142532A1 (en) 2009-08-10 2012-06-07 Monsanto Technology Llc Low volatility auxin herbicide formulations
SI3354657T1 (en) 2009-09-22 2022-05-31 Medicago Inc. Method of preparing plant-derived proteins
US8962584B2 (en) 2009-10-14 2015-02-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Compositions for controlling Varroa mites in bees
BR112012019582B1 (en) 2010-01-14 2021-09-21 Monsanto Technology Llc DNA MOLECULE COMPRISING PLANT REGULATORY ELEMENTS
CA2787674C (en) 2010-01-22 2022-09-06 Dow Agrosciences Llc Excision of transgenes in genetically modified organisms
KR101982126B1 (en) 2010-03-08 2019-05-27 몬산토 테크놀로지 엘엘씨 Polynucleotide Molecules for Gene Regulation in Plants
MX350491B (en) 2010-06-24 2017-09-07 Dow Agrosciences Llc Lowering saturated fatty acid content of plant seeds.
AR081302A1 (en) 2010-06-24 2012-08-01 Brookhaven Science Ass Llc ACCUMULATION OF OMEGA-7 FATTY ACIDS (-7) IN PLANT SEEDS
KR20140016865A (en) 2010-08-30 2014-02-10 다우 아그로사이언시즈 엘엘씨 Sugarcane bacilliform viral(scbv) enhancer and its use in plant functional genomics
BR122021012776B1 (en) 2010-12-17 2022-08-16 Monsanto Technology Llc METHOD TO IMPROVE THE COMPETENCE OF A PLANT CELL FOR BACTERIAL-MEDIATED TRANSFORMATION
KR20130130806A (en) 2010-12-30 2013-12-02 다우 아그로사이언시즈 엘엘씨 Nucleic acid molecules that confer resistance to coleopteran pests
BRPI1107329A2 (en) 2010-12-30 2019-11-19 Dow Agrosciences Llc nucleic acid molecules that target the vacuolar atpase h-subunit that confer resistance to Coleoptera pests, plant transformation vector, transformed cell, as well as methods for controlling a Coleoptera pest population, controlling an infestation by said pest, improving the yield of a crop and to produce a transgenic cell
WO2012092573A2 (en) 2010-12-30 2012-07-05 Dow Agrosciences Llc Nucleic acid molecules that target the vacuolar atpase c subunit and confer resistance to coleopteran pests
TWI620816B (en) 2011-03-23 2018-04-11 苜蓿股份有限公司 Plant derived protein recovery method
WO2012168124A1 (en) 2011-06-06 2012-12-13 Bayer Cropscience Nv Methods and means to modify a plant genome at a preselected site
BR112014003919A2 (en) 2011-08-22 2017-03-14 Bayer Cropscience Ag methods and means for modifying a plant genome
BR112014005958A2 (en) 2011-09-13 2020-10-13 Monsanto Technology Llc agricultural chemical methods and compositions for plant control, method of reducing expression of an accase gene in a plant, microbial expression cassette, method for making a polynucleotide, method of identifying polynucleotides useful in modulating expression of the accase gene and herbicidal composition
CA2848685A1 (en) 2011-09-13 2013-03-21 Monsanto Technology Llc Methods and compositions for weed control comprising topical application of a glutamine synthetase polynucleotide
US10829828B2 (en) 2011-09-13 2020-11-10 Monsanto Technology Llc Methods and compositions for weed control
EP3434780A1 (en) 2011-09-13 2019-01-30 Monsanto Technology LLC Methods and compositions for weed control
US10806146B2 (en) 2011-09-13 2020-10-20 Monsanto Technology Llc Methods and compositions for weed control
BR112014005975A8 (en) 2011-09-13 2017-09-12 Monsanto Technology Llc PLANT CONTROL METHOD, METHOD OF REDUCING EXPRESSION OF A PDS GENE IN A PLANT, MICROBIAL EXPRESSION CASSETTE, METHOD OF MAKING A POLYNUCLEOTIDE, METHOD OF IDENTIFICATION OF POLYNUCLEOTIDES, AND COMPOSITIONS FOR WEED CONTROL
US10760086B2 (en) 2011-09-13 2020-09-01 Monsanto Technology Llc Methods and compositions for weed control
US9840715B1 (en) 2011-09-13 2017-12-12 Monsanto Technology Llc Methods and compositions for delaying senescence and improving disease tolerance and yield in plants
US9920326B1 (en) 2011-09-14 2018-03-20 Monsanto Technology Llc Methods and compositions for increasing invertase activity in plants
BR122019001001B1 (en) 2011-10-26 2019-08-27 Monsanto Technology Llc auxin herbicidal salts, herbicidal application mixture comprising them for use in the elimination and growth control of unwanted plants, as well as methods of controlling unwanted plants and plants susceptible to auxin herbicide
US9506077B2 (en) 2012-02-01 2016-11-29 Dow Agrosciences Llc Synthetic chloroplast transit peptides
CA3151103C (en) 2012-02-02 2024-02-13 Corteva Agriscience Llc Plant transactivation interaction motifs and uses thereof
RU2639517C2 (en) 2012-02-29 2017-12-21 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Enhancer of sugar cane baculovirus (scbv) and its application in functional genomics of plants
AU2013205557B2 (en) 2012-04-17 2016-04-21 Corteva Agriscience Llc Synthetic brassica-derived chloroplast transit peptides
CA2871524C (en) 2012-05-07 2021-07-27 Sangamo Biosciences, Inc. Methods and compositions for nuclease-mediated targeted integration of transgenes
CN104619843B (en) 2012-05-24 2020-03-06 A.B.种子有限公司 Compositions and methods for silencing gene expression
UY34845A (en) 2012-06-04 2014-01-31 Monsanto Technology Llc ? WATER CONCENTRATED HERBICIDE COMPOSITIONS CONTAINING GLIFOSATE SALTS AND DICAMBA SALTS
BR122019026534B1 (en) 2012-06-26 2022-07-19 Monsanto Technology Llc METHOD TO SELECT AN ALPHAFA PLANT WITH IMPROVED FOOD VALUE COMPONENTS FROM A POPULATION OF ALPHAFA PLANTS
BR112015004995B1 (en) 2012-09-07 2023-05-02 Sangamo Biosciences, Inc. METHOD FOR MODIFYING THE GENOME OF A CELL, USE OF A CELL, SEED OR PLANT OBTAINED BY THE SAID METHOD AND SITE-SPECIFIC ZINC FINGER NUCLEASE
UA118090C2 (en) 2012-09-07 2018-11-26 ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі METHOD OF THE METHER OF THE METHOD OF THE INTEGRED EMBLED SUBSTITUTION OF NUCLEIC NUCLE OF NUCLEIC ACID AND NON-NUCLIC ACID AND NON-SPECIAL SPECIES
BR112015008706A2 (en) 2012-10-18 2018-02-06 Monsanto Technology Llc methods and compositions for plant pest control
UY35251A (en) 2013-01-01 2014-07-31 Seeds Ltd Ab ISOLATED DsRNA MOLECULES AND METHODS TO USE THEM TO SILENCE DIANA OF INTEREST MOLECULES
US10683505B2 (en) 2013-01-01 2020-06-16 Monsanto Technology Llc Methods of introducing dsRNA to plant seeds for modulating gene expression
WO2014113493A1 (en) 2013-01-16 2014-07-24 Emory University Cas9-nucleic acid complexes and uses related thereto
US10000767B2 (en) 2013-01-28 2018-06-19 Monsanto Technology Llc Methods and compositions for plant pest control
AU2014223496B2 (en) 2013-02-27 2017-11-30 Monsanto Technology Llc Glyphosate composition for dicamba tank mixtures with improved volatility
AU2014248958A1 (en) 2013-03-13 2015-10-01 Monsanto Technology Llc Methods and compositions for weed control
CA2905027A1 (en) 2013-03-13 2014-10-09 Monsanto Technology Llc Methods and compositions for weed control
US20140283211A1 (en) 2013-03-14 2014-09-18 Monsanto Technology Llc Methods and Compositions for Plant Pest Control
US10568328B2 (en) 2013-03-15 2020-02-25 Monsanto Technology Llc Methods and compositions for weed control
CN103278632B (en) * 2013-04-26 2015-03-11 江苏省农业科学院 ELISA kit for fast detection of corn phosphoenolpyruvate carboxylase (PEPC) gene transgenic crop and use thereof
US9850496B2 (en) 2013-07-19 2017-12-26 Monsanto Technology Llc Compositions and methods for controlling Leptinotarsa
MX359191B (en) 2013-07-19 2018-09-18 Monsanto Technology Llc Compositions and methods for controlling leptinotarsa.
KR20160065952A (en) 2013-10-04 2016-06-09 다우 아그로사이언시즈 엘엘씨 Zea mays metallothionein-like regulatory elements and uses thereof
BR102014025499A2 (en) 2013-10-15 2015-09-29 Dow Agrosciences Llc zea mays regulatory elements and their use
BR102014025574A2 (en) 2013-10-15 2015-09-29 Dow Agrosciences Llc zea mays regulatory elements and uses thereof
AR098295A1 (en) 2013-11-04 2016-05-26 Monsanto Technology Llc COMPOSITIONS AND METHODS TO CONTROL INFESTATIONS OF PESTS AND PARASITES OF THE ARTHROPODS
EP3066110B1 (en) 2013-11-04 2021-12-29 Corteva Agriscience LLC Optimal maize loci
JP6633532B2 (en) 2013-11-04 2020-01-22 ダウ アグロサイエンシィズ エルエルシー Optimal corn loci
WO2015066643A1 (en) 2013-11-04 2015-05-07 Dow Agrosciences Llc Optimal soybean loci
TW201525136A (en) 2013-11-26 2015-07-01 Dow Agrosciences Llc Production of omega-3 long-chain polyunsaturated fatty acids in oilseed crops by a thraustochytrid PUFA synthase
UA119253C2 (en) 2013-12-10 2019-05-27 Біолоджикс, Інк. METHOD FOR VARROA TREATMENT AND VEGETABLES
MX2016008263A (en) 2013-12-20 2017-05-09 Dow Agrosciences Llc Rnapii-140 nucleic acid molecules that confer resistance to coleopteran pests.
BR102014031844A2 (en) 2013-12-20 2015-10-06 Dow Agrosciences Llc RAS and related nucleic acid molecules that confer resistance to Coleoptera and Hemiptera pests
TW201527314A (en) 2013-12-31 2015-07-16 Dow Agrosciences Llc Novel maize ubiquitin promoters
TW201527316A (en) 2013-12-31 2015-07-16 Dow Agrosciences Llc Novel maize ubiquitin promoters
TW201527313A (en) 2013-12-31 2015-07-16 Dow Agrosciences Llc Novel maize ubiquitin promoters
TW201527312A (en) 2013-12-31 2015-07-16 Dow Agrosciences Llc Novel maize ubiquitin promoters
AU2015206585A1 (en) 2014-01-15 2016-07-21 Monsanto Technology Llc Methods and compositions for weed control using EPSPS polynucleotides
BR102015000943A2 (en) 2014-01-17 2016-06-07 Dow Agrosciences Llc increased protein expression in plant
ES2898460T3 (en) 2014-02-27 2022-03-07 Monsanto Technology Llc Compositions and methods for site-directed genomic modification
TW201538518A (en) 2014-02-28 2015-10-16 Dow Agrosciences Llc Root specific expression conferred by chimeric gene regulatory elements
US10563213B2 (en) 2014-03-27 2020-02-18 Medicago Inc. Modified CPMV enhancer elements
EP3420809A1 (en) 2014-04-01 2019-01-02 Monsanto Technology LLC Compositions and methods for controlling insect pests
WO2015168124A1 (en) 2014-04-28 2015-11-05 The Trustees Of The University Of Pennsylvania Compositions and methods for controlling plant growth and development
AU2015255995B2 (en) 2014-05-07 2018-05-10 Dow Agrosciences Llc Dre4 nucleic acid molecules that confer resistance to coleopteran pests
US10988764B2 (en) 2014-06-23 2021-04-27 Monsanto Technology Llc Compositions and methods for regulating gene expression via RNA interference
EP3161138A4 (en) 2014-06-25 2017-12-06 Monsanto Technology LLC Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression
AU2015286165B2 (en) 2014-07-11 2021-03-11 Medicago Inc. Modifying protein production in plants
CN114009454A (en) 2014-07-29 2022-02-08 孟山都技术公司 Compositions and methods for controlling insect pests
EP3037432B1 (en) 2014-12-22 2020-06-17 Dow AgroSciences LLC Nucampholin nucleic acid molecules to control coleopteran insect pests
RU2723049C2 (en) 2015-01-22 2020-06-08 Монсанто Текнолоджи Ллс Compositions and methods for controlling leptinotarsa
US20160264991A1 (en) 2015-03-13 2016-09-15 Dow Agrosciences Llc Rna polymerase i1 nucleic acid molecules to control insect pests
BR112017021903B1 (en) 2015-04-15 2023-12-05 Corteva Agriscience Llc PLANT PROMOTER FOR TRANSGENE EXPRESSION
KR20170136573A (en) 2015-04-15 2017-12-11 다우 아그로사이언시즈 엘엘씨 Plant promoters for transgen expression
BR102016012010A2 (en) 2015-05-29 2020-03-24 Dow Agrosciences Llc NUCLEIC ACID, RIBONUCLEIC ACID (RNA) AND DOUBLE-FILAMENT RIBONUCLEIC ACID (DSRNA) MOLECULE, CELL, PLANT AND SEED USES, PRIMARY PRODUCT, AS WELL AS METHODS TO CONTROL A POPULATION OF HOLIDAYS, OR HOSPITALS, OR HOSPITALS, OR HOSPITALS, OR HOSPITALS THE INCOME OF A CULTURE, AND TO PRODUCE A TRANSGENIC VEGETABLE CELL AND A TRANSGENIC PLANT
US10883103B2 (en) 2015-06-02 2021-01-05 Monsanto Technology Llc Compositions and methods for delivery of a polynucleotide into a plant
US10655136B2 (en) 2015-06-03 2020-05-19 Monsanto Technology Llc Methods and compositions for introducing nucleic acids into plants
US10781456B2 (en) 2015-06-23 2020-09-22 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Carbon-neutral and carbon-positive photorespiration bypass routes supporting higher photosynthetic rate and yield
IL241462A0 (en) 2015-09-10 2015-11-30 Yeda Res & Dev Heterologous engineering of betalain pigments in plants
TW201718861A (en) 2015-09-22 2017-06-01 道禮責任有限公司 Plant promoter and 3'UTR for transgene expression
TW201718862A (en) 2015-09-22 2017-06-01 Dow Agrosciences Llc Plant promoter and 3' UTR for transgene expression
EP3365451B1 (en) 2015-10-22 2020-06-24 Dow Agrosciences LLC Plant promoter for transgene expression
US20170121726A1 (en) 2015-11-04 2017-05-04 Dow Agrosciences Llc Plant promoter for transgene expression
US11021713B2 (en) 2016-05-25 2021-06-01 Cargill, Incorporated Engineered nucleases to generate deletion mutants in plants
IL247752A0 (en) 2016-09-11 2016-11-30 Yeda Res & Dev Compositions and methods for regulating gene expression for targeted mutagenesis
WO2018067265A1 (en) 2016-10-03 2018-04-12 Dow Agrosciences Llc Plant promoter for transgene expression
CN110291199B (en) 2016-10-03 2023-12-22 美国陶氏益农公司 Plant promoters for transgene expression
EP3342780A1 (en) 2016-12-30 2018-07-04 Dow AgroSciences LLC Pre-mrna processing factor 8 (prp8) nucleic acid molecules to control insect pests
EP3630973A1 (en) 2017-05-31 2020-04-08 Tropic Biosciences UK Limited Methods of selecting cells comprising genome editing events
GB201708665D0 (en) 2017-05-31 2017-07-12 Tropic Biosciences Uk Ltd Compositions and methods for increasing extractability of solids from coffee beans
GB201708662D0 (en) 2017-05-31 2017-07-12 Tropic Biosciences Uk Ltd Compositions and methods for increasing shelf-life of banana
CN111278276B (en) 2017-06-28 2023-05-26 美国陶氏益农公司 Plant promoters for transgene expression
AU2018320864B2 (en) 2017-08-22 2024-02-22 Napigen, Inc. Organelle genome modification using polynucleotide guided endonuclease
US11390880B2 (en) 2017-08-31 2022-07-19 Corteva Agriscience Llc Compositions and methods for expressing transgenes using regulatory elements from chlorophyll binding Ab genes
JP7422069B2 (en) 2017-09-19 2024-01-25 トロピック バイオサイエンシーズ ユーケー リミテッド Modifying the specificity of non-coding RNA molecules to silence gene expression in eukaryotic cells
WO2019089402A1 (en) 2017-10-30 2019-05-09 Dow Agrosciences Llc Plant promoter for transgene expression
WO2019133371A1 (en) 2017-12-27 2019-07-04 Pioneer Hi-Bred International, Inc. Transformation of dicot plants
GB201807192D0 (en) 2018-05-01 2018-06-13 Tropic Biosciences Uk Ltd Compositions and methods for reducing caffeine content in coffee beans
EP3802839A1 (en) 2018-06-07 2021-04-14 The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) Nucleic acid constructs and methods of using same
EP3800998A1 (en) 2018-06-07 2021-04-14 The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) Methods of regenerating and transforming cannabis
AU2020204657A1 (en) 2019-01-04 2021-07-29 Pioneer Hi-Bred International, Inc. Engineered nucleases to generate mutations in plants
WO2020181354A1 (en) 2019-03-14 2020-09-17 Mitsubishi Tanabe Pharma Corporation Endogenous plant expression enhancer
GB201903521D0 (en) 2019-03-14 2019-05-01 Tropic Biosciences Uk Ltd No title
GB201903520D0 (en) 2019-03-14 2019-05-01 Tropic Biosciences Uk Ltd Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
GB201903519D0 (en) 2019-03-14 2019-05-01 Tropic Biosciences Uk Ltd Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
GB202103256D0 (en) 2021-03-09 2021-04-21 Tropic Biosciences Uk Ltd Method for silencing genes
EP4351320A1 (en) 2021-06-09 2024-04-17 ImmunityBio, Inc. Methods and systems for producing a protein of interest in a plant
GB202109586D0 (en) 2021-07-02 2021-08-18 Tropic Biosciences Uk Ltd Method for editing banana genes
WO2023275255A1 (en) 2021-07-02 2023-01-05 Tropic Biosciences UK Limited Delay or prevention of browning in banana fruit
GB202112866D0 (en) 2021-09-09 2021-10-27 Tropic Biosciences Uk Ltd Resistance to fusarium wilt in a banana
EP4442817A1 (en) 2023-04-04 2024-10-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Paclitaxel (taxol) biosynthesis pathway
GB202305021D0 (en) 2023-04-04 2023-05-17 Tropic Biosciences Uk Ltd Methods for generating breaks in a genome
CN119351451B (en) 2024-11-11 2026-03-20 山东大学 ZmFS2 gene and its application in maize disease control
CN119351450A (en) 2024-11-11 2025-01-24 山东大学 Application of ZmFS1 gene in prevention and control of maize diseases
WO2026149974A1 (en) 2025-01-10 2026-07-16 Tropic Biosciences UK Limited Reduced browning in banana fruit

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331665B1 (en) * 1990-01-22 2001-12-18 Dekalb Genetics Corp. Insect resistant fertile transgenic corn plants

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4467036A (en) 1981-11-12 1984-08-21 The Board Of Regents Of The University Of Washington Bacillus thuringiensis crystal protein in Escherichia coli
US4448885A (en) 1981-04-27 1984-05-15 Board Of The Regents Of The University Of Washington Bacillus thuringiensis crystal protein in Escherichia coli
WO1984002913A1 (en) 1983-01-17 1984-08-02 Monsanto Co Chimeric genes suitable for expression in plant cells
DE3416978A1 (en) 1983-05-12 1984-12-06 Stauffer Chemical Co., Westport, Conn. TRANSFORMATION OF EUKARYOTIC CELLS MEDIATED BY LIPOSOME
US5380831A (en) 1986-04-04 1995-01-10 Mycogen Plant Science, Inc. Synthetic insecticidal crystal protein gene
US4761373A (en) 1984-03-06 1988-08-02 Molecular Genetics, Inc. Herbicide resistance in plants
EP0160390A3 (en) 1984-04-16 1987-04-08 Sandoz Ltd. Embryogenic callus and cell suspension of inbred corn
CA1301094C (en) 1984-08-31 1992-05-19 Helen Riaboff Whiteley Bacillus thuringiensis crystal protein gene toxin segment
US4830966A (en) 1984-09-07 1989-05-16 Sungene Technologies Corporation Process for regenerating corn
US5100792A (en) 1984-11-13 1992-03-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5371003A (en) 1987-05-05 1994-12-06 Sandoz Ltd. Electrotransformation process
EP0574356A1 (en) 1987-05-05 1993-12-15 Sandoz Ag Plant tissue transformation
EP0292435B1 (en) 1987-05-20 1995-07-26 Ciba-Geigy Ag Zea mays plants and transgenic zea mays plants regenerated from protoplasts or protoplast-derived cells
US5350689A (en) 1987-05-20 1994-09-27 Ciba-Geigy Corporation Zea mays plants and transgenic Zea mays plants regenerated from protoplasts or protoplast-derived cells
US5990387A (en) 1988-06-10 1999-11-23 Pioneer Hi-Bred International, Inc. Stable transformation of plant cells
DE58909876D1 (en) 1988-06-20 2000-09-14 Novartis Ag Process for controlling plant pests with non-plant proteinase inhibitors
GB8818706D0 (en) 1988-08-05 1988-09-07 Ici Plc Dna constructs & plants incorporating them
NZ230375A (en) 1988-09-09 1991-07-26 Lubrizol Genetics Inc Synthetic gene encoding b. thuringiensis insecticidal protein
US5023179A (en) * 1988-11-14 1991-06-11 Eric Lam Promoter enhancer element for gene expression in plant roots
CA2005658A1 (en) 1988-12-19 1990-06-19 Eliahu Zlotkin Insecticidal toxins, genes encoding these toxins, antibodies binding to them and transgenic plant cells and plants expressing these toxins
EP1103616A3 (en) 1989-02-24 2001-06-27 Monsanto Company Synthetic plant genes and method for preparation
EP0400246A1 (en) 1989-05-31 1990-12-05 Plant Genetic Systems, N.V. Prevention of Bt resistance development
WO1991002059A1 (en) 1989-08-01 1991-02-21 Pioneer Hi-Bred International, Inc. Transcriptional activators of anthocyanin biosynthesis as visual markers for plant transformation
US5550318A (en) * 1990-04-17 1996-08-27 Dekalb Genetics Corporation Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
US5177308A (en) 1989-11-29 1993-01-05 Agracetus Insecticidal toxins in plants
US6946587B1 (en) 1990-01-22 2005-09-20 Dekalb Genetics Corporation Method for preparing fertile transgenic corn plants
US6777589B1 (en) 1990-01-22 2004-08-17 Dekalb Genetics Corporation Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
US5484956A (en) 1990-01-22 1996-01-16 Dekalb Genetics Corporation Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin
WO1991016432A1 (en) 1990-04-18 1991-10-31 Plant Genetic Systems N.V. Modified bacillus thuringiensis insecticidal-crystal protein genes and their expression in plant cells
JP3234598B2 (en) 1990-11-23 2001-12-04 プラント・ジエネテイツク・システムズ・エヌ・ベー Transformation method of monocotyledonous plant
DK0539563T3 (en) 1991-05-15 2001-11-12 Monsanto Technology Llc Process for Creating a Transformed Rice Plant
UA48104C2 (en) 1991-10-04 2002-08-15 Новартіс Аг Dna fragment including sequence that codes an insecticide protein with optimization for corn, dna fragment providing directed preferable for the stem core expression of the structural gene of the plant related to it, dna fragment providing specific for the pollen expression of related to it structural gene in the plant, recombinant dna molecule, method for obtaining a coding sequence of the insecticide protein optimized for corn, method of corn plants protection at least against one pest insect
TW261517B (en) 1991-11-29 1995-11-01 Mitsubishi Shozi Kk
US5689052A (en) 1993-12-22 1997-11-18 Monsanto Company Synthetic DNA sequences having enhanced expression in monocotyledonous plants and method for preparation thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331665B1 (en) * 1990-01-22 2001-12-18 Dekalb Genetics Corp. Insect resistant fertile transgenic corn plants

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12484581B2 (en) 2019-09-12 2025-12-02 Nihon Nohyaku Co., Ltd. Agricultural or horticultural insecticide or animal ectoparasite or endoparasite control agent each comprising a condensed heterocyclic compound having a substituted cyclopropane-oxadiazole group or a salt thereof as active ingredient, and method for using the insecticide or the control agent
US12486272B2 (en) 2019-09-12 2025-12-02 Nihon Nohyaku Co., Ltd. Agricultural or horticultural insecticide or animal ectoparasite or endoparasite control agent each comprising an imidazopyridazine compound or a salt thereof as active ingredient, and method for using the insecticide or the control agent
US12516062B2 (en) 2019-09-12 2026-01-06 Nihon Nohyaku Co., Ltd. Agricultural or horticultural insecticide or animal ectoparasite or endoparasite control agent each comprising an imidazopyridazine compound having a substituted cyclopropane-oxadiazole group or a salt thereof as active ingredient, and method for using the insecticide or the control agent

Also Published As

Publication number Publication date
US20030237117A1 (en) 2003-12-25
US6403865B1 (en) 2002-06-11

Similar Documents

Publication Publication Date Title
US6403865B1 (en) Method of producing transgenic maize using direct transformation of commercially important genotypes
CA2096843C (en) Process for transforming monocotyledonous plants
Register III et al. Structure and function of selectable and non-selectable transgenes in maize after introduction by particle bombardment
Vasil et al. Herbicide resistant fertile transgenic wheat plants obtained by microprojectile bombardment of regenerable embryogenic callus
CA2074355C (en) Method of producing fertile transgenic corn plants
US5679558A (en) Transformation of monocot cells
Barcelo et al. Transgenic cereal (tritordeum) plants obtained at high efficiency by microprojectile bombardment of inflorescence tissue
US8350120B2 (en) Plants modified with mini-chromosomes
US8993845B2 (en) Microprojectile bombardment transformation of Brassica
AU1663392A (en) Particle mediated transformation of cotton
Clemente et al. Evaluation of peanut (Arachis hypogaea L.) leaflets from mature zygotic embryos as recipient tissue for biolostic gene transfer
US8222028B2 (en) Plants modified with mini-chromosomes
Sink et al. Somatic cell hybridization
AU2005338055B2 (en) Microprojectile bombardment transformation of Brassica
Ke Plant regeneration and genetic transformation in Kentucky bluegrass (Poa pratensis L.)
AU2011204884A1 (en) Plants modified with mini-chromosomes
HK1025124B (en) Process for transforming monocotyledonous plants
HK1019689B (en) Process for transforming monocotyledonous plants

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION